CNTNAP2 contactin associated protein-like 2
Model Species
Mus musculusGene Aliases
5430425M22Rik, Caspr2, mKIAA0868Models / Rescue Models
53 / 34Rescue Model
-Model Summary
Axon-glia interactions mediated by Cntnap2 and Tag-1 s allow myelinating glial cells to organize ion channels in the underlying axonal membrane.
External Links
Reports related to CNTNAP2 (20 Reports)
# | Type | Title | Author, Year |
---|---|---|---|
1 | Primary | Juxtaparanodal clustering of Shaker-like K channels in myelinated axons depends on Caspr2 and TAG-1. | Poliak S , et al. (2003) |
2 | Additional | Organization of myelinated axons by Caspr and Caspr2 requires the cytoskeletal adapter protein 4.1B. | Horresh I , et al. (2010) |
3 | Additional | Absence of CNTNAP2 leads to epilepsy, neuronal migration abnormalities, and core autism-related deficits. | Peagarikano O , et al. (2011) |
4 | Additional | Exogenous and evoked oxytocin restores social behavior in the Cntnap2 mouse model of autism. | Peagarikano O , et al. (2015) |
5 | Additional | Cerebellar associative sensory learning defects in five mouse autism models. | Kloth AD , et al. (2015) |
6 | Additional | Comprehensive Analysis of the 16p11.2 Deletion and Null Cntnap2 Mouse Models of Autism Spectrum Disorder. | Brunner D , et al. (2015) |
7 | Additional | Cntnap2 knockout rats and mice exhibit epileptiform activity and abnormal sleep/wake physiology. | Thomas AM , et al. (2016) |
8 | Additional | Sex-specific gene-environment interactions underlying ASD-like behaviors. | Schaafsma SM , et al. (2017) |
9 | Additional | Modulation of prefrontal cortex excitation/inhibition balance rescues social behavior in CNTNAP2-deficient mice. | Selimbeyoglu A , et al. (2017) |
10 | Additional | CNTNAP2 stabilizes interneuron dendritic arbors through CASK. | Gao R , et al. (2018) |
11 | Additional | Increased Excitation-Inhibition Ratio Stabilizes Synapse and Circuit Excitability in Four Autism Mouse Models. | Antoine MW , et al. (2019) |
12 | Additional | Targeting Peripheral Somatosensory Neurons to Improve Tactile-Related Phenotypes in ASD Models. | Orefice LL , et al. (2019) |
13 | Additional | IL-17a Promotes Sociability in Mouse Models of Neurodevelopmental Disorders </title> | () |
14 | Additional | Tau Reduction Prevents Key Features of Autism in Mouse Models | Tai C et al. (2020) |
15 | Additional | Autism spectrum disorder-like behavior caused by reduced excitatory synaptic transmission in pyramidal neurons of mouse prefrontal cortex | Sacai H et al. (2020) |
16 | Additional | Dissecting the contribution of host genetics and the microbiome in complex behaviors | Buffington SA et al. (2021) |
17 | Additional | Oxytocin normalizes altered circuit connectivity for social rescue of the Cntnap2 knockout mouse | Choe KY et al. (2022) |
18 | Additional | Somatosensory cortex hyperconnectivity and impaired whisker-dependent responses in Cntnap2 -/- mice | Balasco L et al. (2022) |
19 | Additional | - | Tripathi MK et al. (2023) |
20 | Additional | - | et al. () |
M_CNTNAP2_10_KI_HT
Model Type: Genetic
Model Genotype: Heterozygous
Mutation:
Cntnap2^tlacz/ knockin allele abolishes contactin associated protein-like 2 gene function and instead expresses a tau-LacZ gene and a neo cassette from the Cntnap2 promoter/enhancer elements.
Allele Type: LOF Knockin
Strain of Origin: -
Genetic Background: C57BL/6J*129/SvEv*CD1
Es cell line: -
Model Source: Peles lab
Category | Entity | Value Change | Experimental Paradigm | Age at Testing | Author, Year |
---|---|---|---|---|---|
Sensory | Startle response: acoustic stimulus | No change | Acoustic startle reflex test | 6-8 weeks | Orefice LL , et al. (2019) |
Sensory | Sensorimotor gating: tactile cue | Increased | Response to air puff | 6-8 weeks | Orefice LL , et al. (2019) |
Sensory | Sensorimotor gating: tactile cue | Increased | Prepulse inhibition | 6-8 weeks | Orefice LL , et al. (2019) |
M_CNTNAP2_10_KI_HT_ISOGUVACINE
Model Type: RESCUE-Pharmaceutical
Model Genotype: Heterozygous
Mutation:
Cntnap2^tlacz/ knockin allele abolishes contactin associated protein-like 2 gene function and instead expresses a tau-LacZ gene and a neo cassette from the Cntnap2 promoter/enhancer elements. Isoguvacine, 2 mg/kg, i.p., was administered from P1 to P42 to test if it ameliorated tactile hypersensitivity in ASD models with fewer adverse effects than brain-penetrating benzodiazepines such as midazolam.
Allele Type: LOF Knockin
Strain of Origin: -
Genetic Background: C57BL/6J*129/SvEv*CD1
Es cell line: -
Model Source: Peles lab
Category | Entity | Value Change | Experimental Paradigm | Age at Testing | Author, Year |
---|---|---|---|---|---|
Sensory | Startle response: acoustic stimulus | No adverse effect | Acoustic startle reflex test | 6 weeks | Orefice LL , et al. (2019) |
Sensory | Sensorimotor gating: tactile cue | Restored | Response to air puff | 6 weeks | Orefice LL , et al. (2019) |
Sensory | Sensorimotor gating: tactile cue | Restored | Prepulse inhibition | 6 weeks | Orefice LL , et al. (2019) |
M_CNTNAP2_11_KD
Model Type: Genetic LOF
Model Genotype: Wildtype
Mutation:
Knockdown of cntnap2 in layer 2/3 pyramidal neurons of the developing mouse prefrontal cortex. pregnant icr mice at e14ââ¬â15 were injected intraperitoneally with egfp-pcag plasmid vectors carrying rnai to knockdown the expression of cntnap2 pyramidal neurons.
Allele Type: Wildtype
Strain of Origin: ICR
Genetic Background: ICR
Es cell line: -
Model Source: -
Category | Entity | Value Change | Experimental Paradigm | Age at Testing | Author, Year |
---|---|---|---|---|---|
Motor phenotype | General locomotor activity: Ambulatory activity | No change | Open field test | 8 - 18 weeks | Sacai H et al. (2020) |
Neurophysiology | Synaptic transmission: inhibitory | Decreased | Whole-cell patch clamp | P16 -P24, 8 -11 weeks | Sacai H et al. (2020) |
Neurophysiology | Synaptic transmission: excitatory | Decreased | Whole-cell patch clamp | P16 -P24, 8 - 11 weeks | Sacai H et al. (2020) |
Neurophysiology | Synaptic transmission | Abnormal | Whole-cell patch clamp | P16 -P24, 8 - 11 weeks | Sacai H et al. (2020) |
Neurophysiology | Synaptic neuroreceptor ratio (NMDAR/AMPAR) dependent transmission | No change | Whole-cell patch clamp | 2-3 weeks, 8 - 11 weeks | Sacai H et al. (2020) |
Neurophysiology | Stimulus-spike relationship: inhibitory | Decreased | Whole-cell patch clamp | P16 -P24, 8 -11 weeks | Sacai H et al. (2020) |
Neurophysiology | Presynaptic function: paired-pulse facilitation | No change | Whole-cell patch clamp | 2-3 weeks | Sacai H et al. (2020) |
Neurophysiology | Miniature post synaptic currents: excitatory | No change | Whole-cell patch clamp | 8 - 18 weeks | Sacai H et al. (2020) |
Neurophysiology | Miniature post synaptic current frequency: inhibitory | Decreased | Whole-cell patch clamp | 8 - 18 weeks | Sacai H et al. (2020) |
Neurophysiology | Miniature post synaptic current frequency: excitatory | Decreased | Whole-cell patch clamp | P16 -P24, 8 -11 weeks | Sacai H et al. (2020) |
Neurophysiology | Miniature post synaptic current amplitude: inhibitory | No change | Whole-cell patch clamp | 8 - 18 weeks | Sacai H et al. (2020) |
Neurophysiology | Miniature post synaptic current amplitude: excitatory | Decreased | Whole-cell patch clamp | P16 -P24, 8 -11 weeks | Sacai H et al. (2020) |
Neurophysiology | EPSP-spike relationship | Decreased | Whole-cell patch clamp | P16 -P24, 8 -11 weeks | Sacai H et al. (2020) |
Neurophysiology | Decay kinetics of miniature post synaptic currents | No change | Whole-cell patch clamp | 8 - 18 weeks | Sacai H et al. (2020) |
Repetitive behavior | Self grooming | No change | Grooming behavior assessments | 8 - 18 weeks | Sacai H et al. (2020) |
Repetitive behavior | Repetitive digging | No change | Marble-burying test | 8 - 18 weeks | Sacai H et al. (2020) |
Social behavior | Social interaction | Decreased | Reciprocal social interaction test | 8 - 18 weeks | Sacai H et al. (2020) |
Social behavior | Social approach | Decreased | Partition test | 8 - 18 weeks | Sacai H et al. (2020) |
Social behavior | Social approach | Decreased | Three-chamber social approach test | 8 - 18 weeks | Sacai H et al. (2020) |
Communications | Ultrasonic vocalization: Isolation induced | Decreased | Monitoring ultrasonic vocalizations | P7 | Sacai H et al. (2020) |
Emotion | Exploratory activity | No change | Novel object exploration test | 8 - 18 weeks | Sacai H et al. (2020) |
Emotion | Depression | No change | Forced swim test | 8 - 18 weeks | Sacai H et al. (2020) |
Emotion | Depression | Increased | Tail suspension test | 8 - 18 weeks | Sacai H et al. (2020) |
Emotion | Anxiety | No change | Elevated plus maze test | 8 - 18 weeks | Sacai H et al. (2020) |
Emotion | Anxiety | No change | Light-dark exploration test | 8 - 18 weeks | Sacai H et al. (2020) |
Learning & memory | Spatial working memory | No change | Y-maze test | 8 - 18 weeks | Sacai H et al. (2020) |
Learning & memory | Cognitive flexibility | No change | Operant conditioning paradigm | 8 - 18 weeks | Sacai H et al. (2020) |
Molecular profile | Targeted expression | Decreased | Immunohistochemistry | 8 - 18 weeks | Sacai H et al. (2020) |
M_CNTNAP2_11_KD_CX-546
Model Type: RESCUE-Pharmaceutical
Model Genotype: Wildtype
Mutation:
Intraperitoneal injection of cx546 (25 mg/kg) or vehicle was performed 30 min before the test in cntnap2 knockdown mice.
Allele Type: Wildtype
Strain of Origin: ICR
Genetic Background: ICR
Es cell line: -
Model Source: -
Category | Entity | Value Change | Experimental Paradigm | Age at Testing | Author, Year |
---|---|---|---|---|---|
Neurophysiology | Synaptic transmission | Restored | Whole-cell patch clamp | P16 -P24, 8 - 11 weeks | Sacai H et al. (2020) |
Neurophysiology | Miniature post synaptic currents: excitatory | Side effect | Whole-cell patch clamp | 8 - 18 weeks | Sacai H et al. (2020) |
Neurophysiology | Miniature post synaptic current frequency: inhibitory | Refractory | Whole-cell patch clamp | 8 - 18 weeks | Sacai H et al. (2020) |
Neurophysiology | Miniature post synaptic current amplitude: inhibitory | No adverse effect | Whole-cell patch clamp | 8 - 18 weeks | Sacai H et al. (2020) |
Neurophysiology | Decay kinetics of miniature post synaptic currents | Side effect | Whole-cell patch clamp | 8 - 18 weeks | Sacai H et al. (2020) |
Social behavior | Social interaction | Restored | Reciprocal social interaction test | 8 - 18 weeks | Sacai H et al. (2020) |
Social behavior | Social approach | Restored | Partition test | 8 - 18 weeks | Sacai H et al. (2020) |
Molecular profile | Targeted expression | Restored | Immunohistochemistry | 8 - 18 weeks | Sacai H et al. (2020) |
M_CNTNAP2_11_KO_HM
Model Type: Genetic
Model Genotype: Homozygous
Mutation:
Gene targeted replacement of exon 1 of Cntnap2 gene with a oppositely directed neo gene. A subset of mice were homozygous for Cntnap2 KO and heterozygous for Oxt-Cre (obtained from JAX, #024234) for DREADD experiments targetted to PVN OXT neurons using AAV-OXT-hM3D(Gq)-mCherry or AAVhSyn-DIO-hM3D(Gq)-mCherry; M_CNTNAP2_1_KO_HM crossed to C57BL/6J background for 12 generations
Allele Type: Knockout
Strain of Origin: (129X1/SvJ x 129S1/Sv)F1-Kitl+
Genetic Background: 129S1/Sv * 129X1/SvJ * ICR * C57BL/6J
Es cell line: R1
Model Source: Peles lab
Category | Entity | Value Change | Experimental Paradigm | Age at Testing | Author, Year |
---|---|---|---|---|---|
Neuroanatomy / Ultrastructure / Cytoarchitecture | Neuroreceptor levels: oxt | no change | Autoradiographic analysis | Adult (8 weeks or orlder) | Choe KY et al. (2022) |
Neurophysiology | Neuronal activation | increased | Fluorescence microscopy | Adult (8 weeks or orlder) | Choe KY et al. (2022) |
Neurophysiology | Neuronal activation | increased | Functional magnetic resonance imaging (FMRI)-resting state | Adult (8 weeks or orlder) | Choe KY et al. (2022) |
Neurophysiology | Neuronal activation | increased | Fluorescence microscopy | Adult (8 weeks or orlder) | Choe KY et al. (2022) |
Neurophysiology | Functional magnetic resonance imaging: connectivity | abnormal | Functional magnetic resonance imaging (FMRI)-resting state | Adult (8 weeks or orlder) | Choe KY et al. (2022) |
M_CNTNAP2_11_KO_HM_chETA
Model Type: RESCUE-Genetic
Model Genotype: Homozygous
Mutation:
Gene targeted replacement of exon 1 of Cntnap2 gene with a oppositely directed neo gene. in vivo optogenetic stimulation of NAcSh-targeted OXT release via AAV1-Ef1a-DIO ChETA-EYFP
Allele Type: Knockout
Strain of Origin: (129X1/SvJ x 129S1/Sv)F1-Kitl+
Genetic Background: 129S1/Sv * 129X1/SvJ * ICR * C57BL/6J
Es cell line: R1
Model Source: PMID 34932941
Category | Entity | Value Change | Experimental Paradigm | Age at Testing | Author, Year |
---|---|---|---|---|---|
Social behavior | Social interaction | ameliorated | Reciprocal social interaction test | Adult (8 weeks or orlder) | Choe KY et al. (2022) |
M_CNTNAP2_11_KO_HM_OXT
Model Type: RESCUE-Pharmaceutical
Model Genotype: Homozygous
Mutation:
Gene targeted replacement of exon 1 of Cntnap2 gene with a oppositely directed neo gene. OXT (Sigma, 1 mg/kg i.p. at 1 mg/mL) or saline of the same volume was administeredvia a catheter
Allele Type: Knockout
Strain of Origin: (129X1/SvJ x 129S1/Sv)F1-Kitl+
Genetic Background: 129S1/Sv * 129X1/SvJ * ICR * C57BL/6J
Es cell line: R1
Model Source: PMID 34932941
Category | Entity | Value Change | Experimental Paradigm | Age at Testing | Author, Year |
---|---|---|---|---|---|
Neurophysiology | Functional magnetic resonance imaging: connectivity | ameliorated | Functional magnetic resonance imaging (FMRI)-resting state | Adult (8 weeks or orlder) | Choe KY et al. (2022) |
M_CNTNAP2_11_KO_HM_TGOT
Model Type: RESCUE-Pharmaceutical
Model Genotype: Homozygous
Mutation:
Gene targeted replacement of exon 1 of Cntnap2 gene with a oppositely directed neo gene. bilateral microinjection of TGOT (OXTR agonist) into nucleus accumbens
Allele Type: Knockout
Strain of Origin: (129X1/SvJ x 129S1/Sv)F1-Kitl+
Genetic Background: 129S1/Sv * 129X1/SvJ * ICR * C57BL/6J
Es cell line: R1
Model Source: PMID 34932941
Category | Entity | Value Change | Experimental Paradigm | Age at Testing | Author, Year |
---|---|---|---|---|---|
Social behavior | Social interaction | ameliorated | Reciprocal social interaction test | Adult (8 weeks or orlder) | Choe KY et al. (2022) |
M_CNTNAP2_12_KI_HT_I1253T
Model Type: Genetic
Model Genotype: Heterozygous
Mutation:
Cntnap2^I1254T knock-in mice were generated using CRISPRââ¬âCas9-mediated gene targeting. The targeted missense mutation changes an ATA DNA sequence to ACG in exon 23, which results in an isoleucine to threonine amino acid change in the CNTNAP2 protein. The I1254T mutation in the CNTNAP2 protein corresponds to the pathogenic I1253T mutation in ASD patients. Heterozygous mice carry one copy of the mutant allele.
Allele Type: ASD mutation
Strain of Origin: Not specified
Genetic Background: Not specified
Es cell line: Not specified
Model Source: Weihong Song
Category | Entity | Value Change | Experimental Paradigm | Age at Testing | Author, Year |
---|---|---|---|---|---|
Motor phenotype | General locomotor activity: ambulatory activity | No change | Open field test | 7 weeks | et al. () |
Repetitive behavior | Self grooming | Increased | Grooming behavior assessments | 3 weeks | et al. () |
Social behavior | Social approach | Decreased | Three-chamber social approach test | 7 weeks | et al. () |
Social behavior | Juvenile play | No change | Reciprocal social interaction test | 3 weeks | et al. () |
Communications | Ultrasonic vocalization: isolation induced | Decreased | Monitoring ultrasonic vocalizations | P3-P12 | et al. () |
Developmental profile | Size/growth | No change | Body weight measurement | 3-8 weeks | et al. () |
Developmental profile | Mortality/lethality | No change | Genotypic ratio of progeny from heterozygous parents | 7 weeks | et al. () |
Learning & memory | Spatial working memory | Decreased | T-maze test | 7 weeks | et al. () |
M_CNTNAP2_12_KI_HT_I1253T_C79
Model Type: RESCUE-Genetic
Model Genotype: Heterozygous
Mutation:
Cntnap2^I1254T heterozygous knock-in mice were injected in the medial prefrontal cortex at the age of 3 weeks with the adeno-associated virus (AAV) vector expressing CNTNAP2-C79 protein (AAV-C79) and AAV-EGFP (as the control). C79 is the C-terminal peptide resulting from CNTNAP2 cleavage by alpha-secretase ADAM10.
Allele Type: ASD mutation
Strain of Origin: Not specified
Genetic Background: Not specified
Es cell line: Not specified
Model Source: Weihong Song
M_CNTNAP2_1_KO_HM
Model Type: Genetic
Model Genotype: Homozygous
Mutation:
Gene targeted replacement of exon 1 of Cntnap2 gene with a oppositely directed neo gene.
Allele Type: Knockout
Strain of Origin: (129X1/SvJ x 129S1/Sv)F1-Kitl+
Genetic Background: 129S1/Sv * 129X1/SvJ * ICR
Es cell line: R1
Model Source: Peles lab
Category | Entity | Value Change | Experimental Paradigm | Age at Testing | Author, Year |
---|---|---|---|---|---|
Circadian sleep/wake cycle | NA | Not reported | NA | NA | Poliak S , et al. (2003) |
Motor phenotype | Ataxia | No change | General observations | 20 months | Poliak S , et al. (2003) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Brain morphology | No change | Electron microscopy | Adult | Poliak S , et al. (2003) |
Neurophysiology | NA | Not reported | NA | NA | Poliak S , et al. (2003) |
Repetitive behavior | NA | Not reported | NA | NA | Poliak S , et al. (2003) |
Seizure | NA | Not reported | NA | NA | Poliak S , et al. (2003) |
Sensory | NA | Not reported | NA | NA | Poliak S , et al. (2003) |
Social behavior | NA | Not reported | NA | NA | Poliak S , et al. (2003) |
Physiological parameters | NA | Not reported | NA | NA | Poliak S , et al. (2003) |
Communications | NA | Not reported | NA | NA | Poliak S , et al. (2003) |
Developmental profile | Size/growth | Decreased | General observations | P0 | Poliak S , et al. (2003) |
Emotion | NA | Not reported | NA | NA | Poliak S , et al. (2003) |
Immune response | NA | Not reported | NA | NA | Poliak S , et al. (2003) |
Learning & memory | NA | Not reported | NA | NA | Poliak S , et al. (2003) |
Maternal behavior | NA | Not reported | NA | NA | Poliak S , et al. (2003) |
Molecular profile | Protein localization: synapse | Decreased | Immunohistochemistry | Adult | Poliak S , et al. (2003) |
M_CNTNAP2_2_KO_HM
Model Type: Genetic
Model Genotype: Homozygous
Mutation:
Gene targeted replacement of exon 1 of Cntnap2 gene with a oppositely directed neo gene (Reference: PMID 12963709).
Allele Type: Knockout
Strain of Origin: (129X1/SvJ x 129S1/Sv)F1-Kitl+
Genetic Background: BALB/c * C57BL/6 * 129S1/Sv * 129X1/SvJ * ICR
Es cell line: R1
Model Source: Peles lab
Category | Entity | Value Change | Experimental Paradigm | Age at Testing | Author, Year |
---|---|---|---|---|---|
Circadian sleep/wake cycle | NA | Not reported | NA | NA | Horresh I , et al. (2010) |
Motor phenotype | NA | Not reported | NA | NA | Horresh I , et al. (2010) |
Neuroanatomy / ultrastructure / cytoarchitecture | NA | Not reported | NA | NA | Horresh I , et al. (2010) |
Neurophysiology | NA | Not reported | NA | NA | Horresh I , et al. (2010) |
Repetitive behavior | NA | Not reported | NA | NA | Horresh I , et al. (2010) |
Seizure | NA | Not reported | NA | NA | Horresh I , et al. (2010) |
Sensory | NA | Not reported | NA | NA | Horresh I , et al. (2010) |
Social behavior | NA | Not reported | NA | NA | Horresh I , et al. (2010) |
Physiological parameters | NA | Not reported | NA | NA | Horresh I , et al. (2010) |
Communications | NA | Not reported | NA | NA | Horresh I , et al. (2010) |
Developmental profile | NA | Not reported | NA | NA | Horresh I , et al. (2010) |
Emotion | NA | Not reported | NA | NA | Horresh I , et al. (2010) |
Immune response | NA | Not reported | NA | NA | Horresh I , et al. (2010) |
Learning & memory | NA | Not reported | NA | NA | Horresh I , et al. (2010) |
Maternal behavior | NA | Not reported | NA | NA | Horresh I , et al. (2010) |
Molecular profile | Protein expression level evidence | Abnormal | Immunohistochemistry | Unreported | Horresh I , et al. (2010) |
M_CNTNAP2_2_KO_HM_HCNTNAP2
Model Type: RESCUE-Genetic
Model Genotype: Homozygous
Mutation:
Transgene of HA-tagged construct of human Cntnap2 cDNA, C2FL (full-length), in Cntnap2 knockout mice (PMID 112963709).
Allele Type: Knockout
Strain of Origin: CB6F1 (Transgene); (129X1/SvJ x 129S1/Sv)F1-Kitl+
Genetic Background: BALB/c * C57BL/6 * 129S1/Sv * 129X1/SvJ * ICR
Es cell line: -
Model Source: Peles lab
Category | Entity | Value Change | Experimental Paradigm | Age at Testing | Author, Year |
---|---|---|---|---|---|
Circadian sleep/wake cycle | NA | Not reported | NA | NA | Horresh I , et al. (2010) |
Motor phenotype | NA | Not reported | NA | NA | Horresh I , et al. (2010) |
Neuroanatomy / ultrastructure / cytoarchitecture | NA | Not reported | NA | NA | Horresh I , et al. (2010) |
Neurophysiology | NA | Not reported | NA | NA | Horresh I , et al. (2010) |
Repetitive behavior | NA | Not reported | NA | NA | Horresh I , et al. (2010) |
Seizure | NA | Not reported | NA | NA | Horresh I , et al. (2010) |
Sensory | NA | Not reported | NA | NA | Horresh I , et al. (2010) |
Social behavior | NA | Not reported | NA | NA | Horresh I , et al. (2010) |
Physiological parameters | NA | Not reported | NA | NA | Horresh I , et al. (2010) |
Communications | NA | Not reported | NA | NA | Horresh I , et al. (2010) |
Developmental profile | NA | Not reported | NA | NA | Horresh I , et al. (2010) |
Emotion | NA | Not reported | NA | NA | Horresh I , et al. (2010) |
Immune response | NA | Not reported | NA | NA | Horresh I , et al. (2010) |
Learning & memory | NA | Not reported | NA | NA | Horresh I , et al. (2010) |
Maternal behavior | NA | Not reported | NA | NA | Horresh I , et al. (2010) |
Molecular profile | Protein expression level evidence | Restored | Immunohistochemistry | Unreported | Horresh I , et al. (2010) |
Molecular profile | Protein expression level evidence | Restored | Immunohistochemistry | Unreported | Horresh I , et al. (2010) |
M_CNTNAP2_3_KO_HM_HCNTNAP2D4.1
Model Type: Genetic
Model Genotype: Homozygous
Mutation:
Transgene of HA-tagged construct of human Cntnap2 cDNA with 4.1B binding domain deletion, C2d4.1 (delection of amino acids R1298 to H1304), in Cntnap2 knockout mice (PMID 12963709).
Allele Type: Humanized LOF mutation
Strain of Origin: CB6F1 (Transgene); (129X1/SvJ x 129S1/Sv)F1-Kitl+
Genetic Background: BALB/c * C57BL/6 * 129S1/Sv * 129X1/SvJ * ICR
Es cell line: -
Model Source: Peles lab
Category | Entity | Value Change | Experimental Paradigm | Age at Testing | Author, Year |
---|---|---|---|---|---|
Circadian sleep/wake cycle | NA | Not reported | NA | NA | Horresh I , et al. (2010) |
Motor phenotype | NA | Not reported | NA | NA | Horresh I , et al. (2010) |
Neuroanatomy / ultrastructure / cytoarchitecture | NA | Not reported | NA | NA | Horresh I , et al. (2010) |
Neurophysiology | NA | Not reported | NA | NA | Horresh I , et al. (2010) |
Repetitive behavior | NA | Not reported | NA | NA | Horresh I , et al. (2010) |
Seizure | NA | Not reported | NA | NA | Horresh I , et al. (2010) |
Sensory | NA | Not reported | NA | NA | Horresh I , et al. (2010) |
Social behavior | NA | Not reported | NA | NA | Horresh I , et al. (2010) |
Physiological parameters | NA | Not reported | NA | NA | Horresh I , et al. (2010) |
Communications | NA | Not reported | NA | NA | Horresh I , et al. (2010) |
Developmental profile | NA | Not reported | NA | NA | Horresh I , et al. (2010) |
Emotion | NA | Not reported | NA | NA | Horresh I , et al. (2010) |
Immune response | NA | Not reported | NA | NA | Horresh I , et al. (2010) |
Learning & memory | NA | Not reported | NA | NA | Horresh I , et al. (2010) |
Maternal behavior | NA | Not reported | NA | NA | Horresh I , et al. (2010) |
Molecular profile | Protein expression level evidence | Decreased | Immunohistochemistry | Unreported | Horresh I , et al. (2010) |
Molecular profile | Protein expression level evidence | Decreased | Immunohistochemistry | Unreported | Horresh I , et al. (2010) |
M_CNTNAP2_5_KO_HM
Model Type: Genetic
Model Genotype: Homozygous
Mutation:
Gene targeted replacement of exon 1 of Cntnap2 gene with an oppositely directed neo gene. In Gao et al. 2018 (PMID 29610457) Cntnap2 null mutant mice were crossed with heterozygous transgenic mice carrying the interneuron-specific Gad1-eGFP reporter to generate Cntnap2 null mutant (test animals) and wildtype (controls) mice with the reporter. In PMID 31853066 mice were inbred after colonizing with segmented filamentous bacteria (SFB) from donor mice.
Allele Type: Knockout
Strain of Origin: (129X1/SvJ x 129S1/Sv)F1-Kitl+
Genetic Background: C57BL/6J
Es cell line: R1
Model Source: Peles lab
Category | Entity | Value Change | Experimental Paradigm | Age at Testing | Author, Year |
---|---|---|---|---|---|
Category | Signaling: nitric oxide pathway | Increased | Griess reagent assay | unreported | Tripathi MK et al. (2023) |
Category | Signaling: nitric oxide pathway | Increased | Cyclic nucleotide activity assay | unreported | Tripathi MK et al. (2023) |
Circadian sleep/wake cycle | NA | Not reported | NA | NA | - |
Circadian sleep/wake cycle | NA | Not reported | NA | NA | () |
Circadian sleep/wake cycle | NA | Not reported | NA | NA | Antoine MW , et al. (2019) |
Circadian sleep/wake cycle | NA | Not reported | NA | NA | Gao R , et al. (2018) |
Circadian sleep/wake cycle | NA | Not reported | NA | NA | Selimbeyoglu A , et al. (2017) |
Circadian sleep/wake cycle | NA | Not reported | NA | NA | Schaafsma SM , et al. (2017) |
Circadian sleep/wake cycle | Sleep pattern | Abnormal | Electroencephalogram (eeg) | 4, 8 months | Thomas AM , et al. (2016) |
Circadian sleep/wake cycle | Rapid eye movement sleep (rems) | Decreased | Electroencephalogram (eeg) | 4, 8 months | Thomas AM , et al. (2016) |
Circadian sleep/wake cycle | Locomotor activity in diurnal cycle | No change | Electromyogram (emg) | 4, 8 months | Thomas AM , et al. (2016) |
Circadian sleep/wake cycle | Circadian rhythms: timing/phases of locomotor activity | Abnormal | Electromyogram (emg) | 4, 8 months | Thomas AM , et al. (2016) |
Circadian sleep/wake cycle | Circadian rhythms: timing/phases of locomotor activity | Abnormal | Body temperature measurement | 4, 8 months | Thomas AM , et al. (2016) |
Circadian sleep/wake cycle | NA | Not reported | NA | NA | Brunner D , et al. (2015) |
Circadian sleep/wake cycle | NA | Not reported | NA | NA | Kloth AD , et al. (2015) |
Circadian sleep/wake cycle | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Circadian sleep/wake cycle | NA | Not reported | NA | NA | Peagarikano O , et al. (2011) |
Motor phenotype | NA | Not reported | NA | NA | - |
Motor phenotype | General locomotor activity: ambulatory activity | Increased | Open field test | 7 weeks | et al. () |
Motor phenotype | General locomotor activity: ambulatory activity | No change | Open field test | unreported | Tripathi MK et al. (2023) |
Motor phenotype | General locomotor activity: ambulatory activity | Increased | Open field test | 3-6 months | Balasco L et al. (2022) |
Motor phenotype | NA | Not reported | NA | NA | () |
Motor phenotype | NA | Not reported | NA | NA | Antoine MW , et al. (2019) |
Motor phenotype | NA | Not reported | NA | NA | Gao R , et al. (2018) |
Motor phenotype | Spontaneous movement | Increased | Open field test | Adult | Selimbeyoglu A , et al. (2017) |
Motor phenotype | General locomotor activity | Increased | Reciprocal social interaction test | Adult | Selimbeyoglu A , et al. (2017) |
Motor phenotype | General locomotor activity | Increased | Open field test | P40 | Schaafsma SM , et al. (2017) |
Motor phenotype | NA | Not reported | NA | NA | Thomas AM , et al. (2016) |
Motor phenotype | Righting response | Decreased | Righting reflex test | P4, p7 | Brunner D , et al. (2015) |
Motor phenotype | Righting response | Decreased | Negative geotaxis test | P4, p7 | Brunner D , et al. (2015) |
Motor phenotype | Negative geotaxis | No change | Negative geotaxis test | P4, p7, p15 | Brunner D , et al. (2015) |
Motor phenotype | Jerky movement | Increased | Observation of repetitive behavior | 3 months | Brunner D , et al. (2015) |
Motor phenotype | General locomotor activity | Increased | Home cage behavior | 3 months | Brunner D , et al. (2015) |
Motor phenotype | Gait | Decreased | Footprint analysis | 1 month, 2 months | Brunner D , et al. (2015) |
Motor phenotype | Gait | Decreased | Running stride analysis | 1 month, 2 months | Brunner D , et al. (2015) |
Motor phenotype | Gait | No change | Running stride analysis | 2-4 months | Kloth AD , et al. (2015) |
Motor phenotype | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Motor phenotype | Motor coordination and balance | Increased | Accelerating rotarod test | Unreported | Peagarikano O , et al. (2011) |
Motor phenotype | General locomotor activity | Increased | Open field test | Unreported | Peagarikano O , et al. (2011) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Neuronal number: enteric neurons | No change | Immunohistochemistry | 9 weeks | - |
Neuroanatomy / ultrastructure / cytoarchitecture | NA | Not reported | NA | NA | - |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Synapse density | Decreased | Western blot | unreported | Tripathi MK et al. (2023) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Neuronal number: inhibitory neurons | Decreased | Immunofluorescence staining | unreported | Tripathi MK et al. (2023) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Neuronal number: excitatory neurons | Decreased | Immunofluorescence staining | unreported | Tripathi MK et al. (2023) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Dendritic architecture: spine density | Decreased | Golgi-Cox staining | unreported | Tripathi MK et al. (2023) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Neuronal number: Inhibitory neurons | No change | Quantitative PCR (qRT-PCR) | 3-6 months | Balasco L et al. (2022) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Neuronal number: Excitatory neurons | Increased | Quantitative PCR (qRT-PCR) | 3-6 months | Balasco L et al. (2022) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Brain size | Increased | Measurement of tissue weight | 9-10 months | Tai C et al. (2020) |
Neuroanatomy / ultrastructure / cytoarchitecture | NA | Not reported | NA | NA | () |
Neuroanatomy / ultrastructure / cytoarchitecture | NA | Not reported | NA | NA | Antoine MW , et al. (2019) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Dendritic architecture: dendritic tree complexity | No change | Sholl analysis | 6 months | Gao R , et al. (2018) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Dendritic architecture: dendritic tree complexity | Decreased | Sholl analysis | 5 months | Gao R , et al. (2018) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Dendritic architecture: dendritic length | No change | Golgi-cox staining | 6 months | Gao R , et al. (2018) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Dendritic architecture: dendritic length | Decreased | Golgi-cox staining | 5 months | Gao R , et al. (2018) |
Neuroanatomy / ultrastructure / cytoarchitecture | NA | Not reported | NA | NA | Selimbeyoglu A , et al. (2017) |
Neuroanatomy / ultrastructure / cytoarchitecture | NA | Not reported | NA | NA | Schaafsma SM , et al. (2017) |
Neuroanatomy / ultrastructure / cytoarchitecture | NA | Not reported | NA | NA | Thomas AM , et al. (2016) |
Neuroanatomy / ultrastructure / cytoarchitecture | NA | Not reported | NA | NA | Brunner D , et al. (2015) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Neuronal number: purkinje cells | No change | Histology | 2-4 months | Kloth AD , et al. (2015) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Dendritic architecture: spine density | No change | Sholl analysis | 2-4 months | Kloth AD , et al. (2015) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Dendritic architecture: dendritic tree complexity | No change | Sholl analysis | 2-4 months | Kloth AD , et al. (2015) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Cerebellar morphology: molecular layer thickness | No change | Histology | 2-4 months | Kloth AD , et al. (2015) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Cerebellar morphology: granule cell layer thickness | No change | Histology | 2-4 months | Kloth AD , et al. (2015) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Neuronal number: oxytocin expressing | Decreased | Immunohistochemistry | 4 weeks | Peagarikano O , et al. (2015) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Neuronal number: oxytocin expressing | No change | Immunohistochemistry | P7 | Peagarikano O , et al. (2015) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Neuronal number | No change | Stereology | 4 weeks | Peagarikano O , et al. (2015) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Neuronal number | No change | Immunohistochemistry | 4 weeks | Peagarikano O , et al. (2015) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Neuronal number: interneurons | Decreased | Immunohistochemistry | P14 | Peagarikano O , et al. (2011) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Neuronal migration | Abnormal | Immunohistochemistry | P14 | Peagarikano O , et al. (2011) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Cortical lamination | Abnormal | Immunohistochemistry | Unreported | Peagarikano O , et al. (2011) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Brain morphology | No change | Histology | 6 months | Peagarikano O , et al. (2011) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Brain cytoarchitecture | Abnormal | Immunohistochemistry | P7 | Peagarikano O , et al. (2011) |
Neurophysiology | Action potential property: firing rate | No change | Whole-cell voltage clamp | P42-p92 | - |
Neurophysiology | Oxidative stress in neurons | Increased | Western blot | unreported | Tripathi MK et al. (2023) |
Neurophysiology | Functional magnetic resonance imaging: connectivity | Increased | Functional magnetic resonance imaging (FMRI)-resting state | 3-6 months | Balasco L et al. (2022) |
Neurophysiology | Neuronal activation | Increased | Immunohistochemistry | Adult, 2-5 months, 9-12 months | () |
Neurophysiology | Synaptic plasticity | Decreased | Whole-cell current clamp | P17-p23 | Antoine MW , et al. (2019) |
Neurophysiology | NA | Not reported | NA | NA | Gao R , et al. (2018) |
Neurophysiology | Neuronal activation: novel object interaction | Increased | Fiber photometry | Adult | Selimbeyoglu A , et al. (2017) |
Neurophysiology | Neuronal activation: non-familiar social interaction | Increased | Fiber photometry | Adult | Selimbeyoglu A , et al. (2017) |
Neurophysiology | Neuronal activation: locomotion | No change | Fiber photometry | Adult | Selimbeyoglu A , et al. (2017) |
Neurophysiology | Neuronal activation: familiar social interaction | Increased | Fiber photometry | Adult | Selimbeyoglu A , et al. (2017) |
Neurophysiology | Neuronal activation | Abnormal | Fiber photometry | Adult | Selimbeyoglu A , et al. (2017) |
Neurophysiology | NA | Not reported | NA | NA | Schaafsma SM , et al. (2017) |
Neurophysiology | NA | Not reported | NA | NA | Thomas AM , et al. (2016) |
Neurophysiology | NA | Not reported | NA | NA | Brunner D , et al. (2015) |
Neurophysiology | NA | Not reported | NA | NA | Kloth AD , et al. (2015) |
Neurophysiology | Neurotransmitter release: neurohypophysial | Decreased | Radioimmunoassay (ria) | 4 weeks | Peagarikano O , et al. (2015) |
Neurophysiology | Network excitability | Decreased | Calcium imaging | 2-4 months | Peagarikano O , et al. (2011) |
Neurophysiology | Action potential property: amplitude | No change | Calcium imaging | 2-4 months | Peagarikano O , et al. (2011) |
Repetitive behavior | NA | Not reported | NA | NA | - |
Repetitive behavior | Self grooming: perseveration | Increased | Novel cage test | 3-4 months | Tai C et al. (2020) |
Repetitive behavior | NA | Not reported | NA | NA | () |
Repetitive behavior | NA | Not reported | NA | NA | Antoine MW , et al. (2019) |
Repetitive behavior | NA | Not reported | NA | NA | Gao R , et al. (2018) |
Repetitive behavior | NA | Not reported | NA | NA | Selimbeyoglu A , et al. (2017) |
Repetitive behavior | NA | Not reported | NA | NA | Schaafsma SM , et al. (2017) |
Repetitive behavior | Self grooming: perseveration | Increased | Grooming behavior assessments | 8 weeks | Thomas AM , et al. (2016) |
Repetitive behavior | NA | Not reported | NA | NA | Brunner D , et al. (2015) |
Repetitive behavior | NA | Not reported | NA | NA | Kloth AD , et al. (2015) |
Repetitive behavior | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Repetitive behavior | Self grooming: perseveration | Increased | General observations | Unreported | Peagarikano O , et al. (2011) |
Repetitive behavior | Perseveration | Increased | T-maze test | Unreported | Peagarikano O , et al. (2011) |
Seizure | NA | Not reported | NA | NA | - |
Seizure | Electroencephalogram (eeg): signature of seizure/epilepsy | Decreased | Electroencephalogram (eeg) | 7-11 months | Tai C et al. (2020) |
Seizure | NA | Not reported | NA | NA | () |
Seizure | NA | Not reported | NA | NA | Antoine MW , et al. (2019) |
Seizure | NA | Not reported | NA | NA | Gao R , et al. (2018) |
Seizure | NA | Not reported | NA | NA | Selimbeyoglu A , et al. (2017) |
Seizure | NA | Not reported | NA | NA | Schaafsma SM , et al. (2017) |
Seizure | Seizures | No change | Electroencephalogram (eeg) | 4, 8 months | Thomas AM , et al. (2016) |
Seizure | Absence seizures | Increased | Electroencephalogram (eeg) | 4, 8 months | Thomas AM , et al. (2016) |
Seizure | NA | Not reported | NA | NA | Brunner D , et al. (2015) |
Seizure | NA | Not reported | NA | NA | Kloth AD , et al. (2015) |
Seizure | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Seizure | Seizures | Increased | General observations | 6 months | Peagarikano O , et al. (2011) |
Seizure | Seizures | Abnormal | Electroencephalogram (eeg) | 6 months | Peagarikano O , et al. (2011) |
Sensory | NA | Not reported | NA | NA | - |
Sensory | Tactile memory | Decreased | Textured novel object recognition test (T-NORT) | 3-6 months | Balasco L et al. (2022) |
Sensory | Sensory-evoked response: excitation: tactile stimulus | Increased | In situ hybridization (ISH) | 3-6 months | Balasco L et al. (2022) |
Sensory | NA | Not reported | NA | NA | () |
Sensory | NA | Not reported | NA | NA | Antoine MW , et al. (2019) |
Sensory | NA | Not reported | NA | NA | Gao R , et al. (2018) |
Sensory | NA | Not reported | NA | NA | Selimbeyoglu A , et al. (2017) |
Sensory | NA | Not reported | NA | NA | Schaafsma SM , et al. (2017) |
Sensory | NA | Not reported | NA | NA | Thomas AM , et al. (2016) |
Sensory | Startle response: acoustic stimulus | No change | Acoustic startle reflex test | 2 months | Brunner D , et al. (2015) |
Sensory | Sensorimotor gating | Increased | Prepulse inhibition | 2 months | Brunner D , et al. (2015) |
Sensory | NA | Not reported | NA | NA | Kloth AD , et al. (2015) |
Sensory | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Sensory | Startle response: acoustic stimulus | No change | Acoustic startle reflex test | Unreported | Peagarikano O , et al. (2011) |
Sensory | Pain or nociception | Increased | Hot plate test | Unreported | Peagarikano O , et al. (2011) |
Sensory | Olfaction | Increased | Buried food test | Unreported | Peagarikano O , et al. (2011) |
Social behavior | NA | Not reported | NA | NA | - |
Social behavior | Social interaction | Decreased | Reciprocal social interaction test | 7 weeks | et al. () |
Social behavior | Social approach | Decreased | Three-chamber social approach test | 7 weeks | et al. () |
Social behavior | Social approach | Decreased | Three-chamber social approach test | unreported | Tripathi MK et al. (2023) |
Social behavior | Social scent marking or recognition | Decreased | Olfactory habituation-dishabituation test | 7-11 months | Tai C et al. (2020) |
Social behavior | Social interaction | No change | Reciprocal social interaction test | 7-11 months | Tai C et al. (2020) |
Social behavior | Social approach | No change | Three-chamber social approach test | 7-11 months | Tai C et al. (2020) |
Social behavior | Nest building behavior | Decreased | Nest building assay | 7-11 months | Tai C et al. (2020) |
Social behavior | Social approach | Decreased | Three-chamber social approach test | Adult | () |
Social behavior | NA | Not reported | NA | NA | Antoine MW , et al. (2019) |
Social behavior | NA | Not reported | NA | NA | Gao R , et al. (2018) |
Social behavior | Social interaction | Decreased | Reciprocal social interaction test | Adult | Selimbeyoglu A , et al. (2017) |
Social behavior | Inanimate object preference | Increased | Novel object recognition test | Adult | Selimbeyoglu A , et al. (2017) |
Social behavior | Social habituation | Decreased | Social recognition test | 6 weeks | Schaafsma SM , et al. (2017) |
Social behavior | Social habituation | No change | Social recognition test | 6 weeks | Schaafsma SM , et al. (2017) |
Social behavior | Social dishabituation | Decreased | Social recognition test | 6 weeks | Schaafsma SM , et al. (2017) |
Social behavior | Social interaction | Decreased | Reciprocal social interaction test | 7 weeks | Thomas AM , et al. (2016) |
Social behavior | Social memory | No change | Three-chamber social approach test | 2 months | Brunner D , et al. (2015) |
Social behavior | Social interaction | No change | Reciprocal social interaction test | 6.4-7.4 weeks | Brunner D , et al. (2015) |
Social behavior | Social interaction | No change | Three-chamber social approach test | 2 months | Brunner D , et al. (2015) |
Social behavior | Mating behavior | Decreased | Scent marking test | 2 months | Brunner D , et al. (2015) |
Social behavior | Mating behavior | No change | Scent marking test | 2 months | Brunner D , et al. (2015) |
Social behavior | NA | Not reported | NA | NA | Kloth AD , et al. (2015) |
Social behavior | Social interaction | Decreased | Reciprocal social interaction test | 4-6 weeks | Peagarikano O , et al. (2015) |
Social behavior | Social interaction | Decreased | Three-chamber social approach test | Unreported | Peagarikano O , et al. (2011) |
Social behavior | Nest building behavior | Decreased | General observations | Unreported | Peagarikano O , et al. (2011) |
Social behavior | Juvenile play | Decreased | Reciprocal social interaction test | P21 | Peagarikano O , et al. (2011) |
Physiological parameters | NA | Not reported | NA | NA | - |
Physiological parameters | Digestive system function: gastrointestinal motility: peristaltic reflexes | Decreased | In vitro analysis of colonic migrating motor complexes (CMMCs) | 9 weeks | - |
Physiological parameters | Digestive system function: gastrointestinal motility: colonic motility | Increased | Measurement of colonic motility | 9 weeks | - |
Physiological parameters | Digestive system function: gastrointestinal motility: colonic motility | Increased | In vitro analysis of colonic migrating motor complexes (CMMCs) | 9 weeks | - |
Physiological parameters | Digestive system function: gastrointestinal motility | Decreased | Intestinal transit time | 9 weeks | - |
Physiological parameters | Digestive system function: fecal composition | No change | Fecal pellet measurements | 9 weeks | - |
Physiological parameters | NA | Not reported | NA | NA | () |
Physiological parameters | NA | Not reported | NA | NA | Antoine MW , et al. (2019) |
Physiological parameters | NA | Not reported | NA | NA | Gao R , et al. (2018) |
Physiological parameters | NA | Not reported | NA | NA | Selimbeyoglu A , et al. (2017) |
Physiological parameters | NA | Not reported | NA | NA | Schaafsma SM , et al. (2017) |
Physiological parameters | NA | Not reported | NA | NA | Thomas AM , et al. (2016) |
Physiological parameters | Core body temperature | No change | Body temperature measurement | 4, 8 months | Thomas AM , et al. (2016) |
Physiological parameters | NA | Not reported | NA | NA | Brunner D , et al. (2015) |
Physiological parameters | Core body temperature | No change | Body weight measurement | P4, p7, p15 | Brunner D , et al. (2015) |
Physiological parameters | NA | Not reported | NA | NA | Kloth AD , et al. (2015) |
Physiological parameters | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Physiological parameters | NA | Not reported | NA | NA | Peagarikano O , et al. (2011) |
Communications | NA | Not reported | NA | NA | - |
Communications | Ultrasonic vocalization: isolation induced | Decreased | Monitoring ultrasonic vocalizations | P5 | Tai C et al. (2020) |
Communications | NA | Not reported | NA | NA | () |
Communications | NA | Not reported | NA | NA | Antoine MW , et al. (2019) |
Communications | NA | Not reported | NA | NA | Gao R , et al. (2018) |
Communications | NA | Not reported | NA | NA | Selimbeyoglu A , et al. (2017) |
Communications | Ultrasonic vocalization: isolation induced | Decreased | Monitoring ultrasonic vocalizations | P3 | Schaafsma SM , et al. (2017) |
Communications | NA | Not reported | NA | NA | Thomas AM , et al. (2016) |
Communications | Ultrasonic vocalization: isolation induced | No change | Monitoring ultrasonic vocalizations | P4, p7, p15 | Brunner D , et al. (2015) |
Communications | Ultrasonic vocalization: interaction induced: opposite sex stimulus | Decreased | Scent marking test | Adult | Brunner D , et al. (2015) |
Communications | NA | Not reported | NA | NA | Kloth AD , et al. (2015) |
Communications | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Communications | Ultrasonic vocalization | Decreased | Monitoring ultrasonic vocalizations | P3-p12 | Peagarikano O , et al. (2011) |
Developmental profile | Size/growth | No change | Body weight measurement | 9 weeks | - |
Developmental profile | NA | Not reported | NA | NA | - |
Developmental profile | Digestive system morphology: GI tract wall | No change | Histology | 11 weeks | - |
Developmental profile | Digestive system morphology: GI tract length | No change | Gross necroscopy | 11 weeks | - |
Developmental profile | NA | Not reported | NA | NA | () |
Developmental profile | NA | Not reported | NA | NA | Antoine MW , et al. (2019) |
Developmental profile | NA | Not reported | NA | NA | Gao R , et al. (2018) |
Developmental profile | NA | Not reported | NA | NA | Selimbeyoglu A , et al. (2017) |
Developmental profile | NA | Not reported | NA | NA | Schaafsma SM , et al. (2017) |
Developmental profile | Size/growth | Decreased | Body weight measurement | 7-13 weeks | Thomas AM , et al. (2016) |
Developmental profile | Size/growth | Decreased | General observations | P4, p7, p15, 1 month, 2 months, 2.7 months, 3 months | Brunner D , et al. (2015) |
Developmental profile | Developmental trajectory | Increased | Developmental milestone measurements | P4 | Brunner D , et al. (2015) |
Developmental profile | Developmental trajectory | Decreased | Developmental milestone measurements | P13 | Brunner D , et al. (2015) |
Developmental profile | Developmental trajectory | Increased | Negative geotaxis test | P15 | Brunner D , et al. (2015) |
Developmental profile | NA | Not reported | NA | NA | Kloth AD , et al. (2015) |
Developmental profile | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Developmental profile | Size/growth | No change | General observations | Unreported | Peagarikano O , et al. (2011) |
Developmental profile | General characteristics | No change | General observations | Unreported | Peagarikano O , et al. (2011) |
Emotion | NA | Not reported | NA | NA | - |
Emotion | Anxiety | Increased | Elevated plus maze test | unreported | Tripathi MK et al. (2023) |
Emotion | Exploratory activity | No change | Textured novel object recognition test (T-NORT) | 3-6 months | Balasco L et al. (2022) |
Emotion | Anxiety | No change | Open field test | 3-6 months | Balasco L et al. (2022) |
Emotion | Anxiety | No change | Open field test | 7-11 months | Tai C et al. (2020) |
Emotion | Anxiety | No change | Elevated plus maze | 7-11 months | Tai C et al. (2020) |
Emotion | NA | Not reported | NA | NA | () |
Emotion | NA | Not reported | NA | NA | Antoine MW , et al. (2019) |
Emotion | NA | Not reported | NA | NA | Gao R , et al. (2018) |
Emotion | NA | Not reported | NA | NA | Selimbeyoglu A , et al. (2017) |
Emotion | Anxiety | Decreased | Open field test | P40 | Schaafsma SM , et al. (2017) |
Emotion | Exploratory activity | Increased | Open field test | 8-9 weeks | Thomas AM , et al. (2016) |
Emotion | Exploratory activity | Decreased | Three-chamber social approach test | 2 months | Brunner D , et al. (2015) |
Emotion | Anxiety | No change | Marble-burying test | 2 months | Brunner D , et al. (2015) |
Emotion | NA | Not reported | NA | NA | Kloth AD , et al. (2015) |
Emotion | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Emotion | Anxiety | No change | Light-dark exploration test | Unreported | Peagarikano O , et al. (2011) |
Immune response | NA | Not reported | NA | NA | - |
Immune response | NA | Not reported | NA | NA | () |
Immune response | NA | Not reported | NA | NA | Antoine MW , et al. (2019) |
Immune response | NA | Not reported | NA | NA | Gao R , et al. (2018) |
Immune response | NA | Not reported | NA | NA | Selimbeyoglu A , et al. (2017) |
Immune response | NA | Not reported | NA | NA | Schaafsma SM , et al. (2017) |
Immune response | NA | Not reported | NA | NA | Thomas AM , et al. (2016) |
Immune response | NA | Not reported | NA | NA | Brunner D , et al. (2015) |
Immune response | NA | Not reported | NA | NA | Kloth AD , et al. (2015) |
Immune response | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Immune response | Astrogliosis | Increased | Western blot | 6 months | Peagarikano O , et al. (2011) |
Learning & memory | NA | Not reported | NA | NA | - |
Learning & memory | Spatial working memory | Decreased | T-maze test | 7 weeks | et al. () |
Learning & memory | Object recognition memory | Decreased | Novel object recognition test | unreported | Tripathi MK et al. (2023) |
Learning & memory | Olfactory learning and memory | No change | Olfactory habituation-dishabituation test | 7-11 months | Tai C et al. (2020) |
Learning & memory | Cognitive flexibility | No change | Water t-maze test | 7-11 months | Tai C et al. (2020) |
Learning & memory | NA | Not reported | NA | NA | () |
Learning & memory | NA | Not reported | NA | NA | Antoine MW , et al. (2019) |
Learning & memory | NA | Not reported | NA | NA | Gao R , et al. (2018) |
Learning & memory | NA | Not reported | NA | NA | Selimbeyoglu A , et al. (2017) |
Learning & memory | NA | Not reported | NA | NA | Schaafsma SM , et al. (2017) |
Learning & memory | NA | Not reported | NA | NA | Thomas AM , et al. (2016) |
Learning & memory | Spatial working memory | Increased | Water t-maze test | 2 months | Brunner D , et al. (2015) |
Learning & memory | Cognitive flexibility | No change | Water t-maze test | 2 months | Brunner D , et al. (2015) |
Learning & memory | Spatial learning | No change | Water y-maze test | 2-4 months | Kloth AD , et al. (2015) |
Learning & memory | Eye blink conditioning: extinction and reactivation | No change | Eyeblink conditioning | 2-4 months | Kloth AD , et al. (2015) |
Learning & memory | Eye blink conditioning | No change | Eyeblink conditioning | 2-4 months | Kloth AD , et al. (2015) |
Learning & memory | Eye blink conditioning | Decreased | Eyeblink conditioning | 2-4 months | Kloth AD , et al. (2015) |
Learning & memory | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Learning & memory | Spatial learning | No change | Morris water maze test | Unreported | Peagarikano O , et al. (2011) |
Learning & memory | Object recognition memory | No change | General observations | Unreported | Peagarikano O , et al. (2011) |
Learning & memory | Cognitive flexibility | Decreased | Morris water maze test | Unreported | Peagarikano O , et al. (2011) |
Maternal behavior | NA | Not reported | NA | NA | - |
Maternal behavior | NA | Not reported | NA | NA | () |
Maternal behavior | NA | Not reported | NA | NA | Antoine MW , et al. (2019) |
Maternal behavior | NA | Not reported | NA | NA | Gao R , et al. (2018) |
Maternal behavior | NA | Not reported | NA | NA | Selimbeyoglu A , et al. (2017) |
Maternal behavior | NA | Not reported | NA | NA | Schaafsma SM , et al. (2017) |
Maternal behavior | NA | Not reported | NA | NA | Thomas AM , et al. (2016) |
Maternal behavior | Maternal nurturing | No change | General observations | P4, p7 | Brunner D , et al. (2015) |
Maternal behavior | NA | Not reported | NA | NA | Kloth AD , et al. (2015) |
Maternal behavior | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Maternal behavior | NA | Not reported | NA | NA | Peagarikano O , et al. (2011) |
Molecular profile | NA | Not reported | NA | NA | - |
Molecular profile | Targeted expression | Decreased | Western blot | unreported | Tripathi MK et al. (2023) |
Molecular profile | Signaling: PKA pathway | No change | Cyclic nucleotide activity assay | unreported | Tripathi MK et al. (2023) |
Molecular profile | Signaling: nitric oxide pathway | Increased | Griess reagent assay | unreported | Tripathi MK et al. (2023) |
Molecular profile | Signaling: nitric oxide pathway | Increased | Cyclic nucleotide activity assay | unreported | Tripathi MK et al. (2023) |
Molecular profile | Signaling: pi3k/akt pathway | Increased | Western blot | 6-7 months | Tai C et al. (2020) |
Molecular profile | Signaling: mtor pathway | Increased | Western blot | 6-7 months | Tai C et al. (2020) |
Molecular profile | NA | Not reported | NA | NA | () |
Molecular profile | NA | Not reported | NA | NA | Antoine MW , et al. (2019) |
Molecular profile | Targeted expression | Decreased | Western blot | 5 months | Gao R , et al. (2018) |
Molecular profile | Protein localization: membrane | Decreased | Western blot | 5 months | Gao R , et al. (2018) |
Molecular profile | Protein expression level evidence | No change | Western blot | 5 months | Gao R , et al. (2018) |
Molecular profile | NA | Not reported | NA | NA | Selimbeyoglu A , et al. (2017) |
Molecular profile | Chromatin modification | Decreased | Quantitative pcr (qrt-pcr) | P40 | Schaafsma SM , et al. (2017) |
Molecular profile | NA | Not reported | NA | NA | Thomas AM , et al. (2016) |
Molecular profile | NA | Not reported | NA | NA | Brunner D , et al. (2015) |
Molecular profile | NA | Not reported | NA | NA | Kloth AD , et al. (2015) |
Molecular profile | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Molecular profile | NA | Not reported | NA | NA | Peagarikano O , et al. (2011) |
M_CNTNAP2_5_KO_HM_7-NITROINDAZOLE
Model Type: RESCUE-Pharmacological
Model Genotype: Homozygous
Mutation:
Cntnap2 knockout (MGI:2677631) mice were treated with neuronal nitric oxide synthase (nNOS) inhibitor, 7-nitroindazole (7-NI), for 10 consecutive days. The pharmacological interventions were performed by daily intraperitoneal (IP) injection at a dose of 80 mg/kg.
Allele Type: Knockout
Strain of Origin: -
Genetic Background: C57BL/6J
Es cell line: -
Model Source: 37212048
Category | Entity | Value Change | Experimental Paradigm | Age at Testing | Author, Year |
---|---|---|---|---|---|
Category | Signaling: nitric oxide pathway | Restored | Griess reagent assay | unreported | Tripathi MK et al. (2023) |
Category | Signaling: nitric oxide pathway | Restored | Cyclic nucleotide activity assay | unreported | Tripathi MK et al. (2023) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Synapse density | Ameliorated | Western blot | unreported | Tripathi MK et al. (2023) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Neuronal number: inhibitory neurons | Ameliorated | Immunofluorescence staining | unreported | Tripathi MK et al. (2023) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Neuronal number: excitatory neurons | Ameliorated | Immunofluorescence staining | unreported | Tripathi MK et al. (2023) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Dendritic architecture: spine density | Ameliorated | Golgi-Cox staining | unreported | Tripathi MK et al. (2023) |
Neurophysiology | Oxidative stress in neurons | Ameliorated | Western blot | unreported | Tripathi MK et al. (2023) |
Social behavior | Social approach | Restored | Three-chamber social approach test | unreported | Tripathi MK et al. (2023) |
Emotion | Anxiety | Restored | Elevated plus maze test | unreported | Tripathi MK et al. (2023) |
Learning & memory | Object recognition memory | Restored | Novel object recognition test | unreported | Tripathi MK et al. (2023) |
Molecular profile | Signaling: PKA pathway | No adverse effect | Cyclic nucleotide activity assay | unreported | Tripathi MK et al. (2023) |
Molecular profile | Signaling: nitric oxide pathway | Restored | Griess reagent assay | unreported | Tripathi MK et al. (2023) |
Molecular profile | Signaling: nitric oxide pathway | Restored | Cyclic nucleotide activity assay | unreported | Tripathi MK et al. (2023) |
M_CNTNAP2_5_KO_HM_AVP-1
Model Type: RESCUE-Pharmaceutical
Model Genotype: Homozygous
Mutation:
Cntnap2 KO (equal male:female ratio) juvenile (4-6 wks old) mice were acutely treated with 10 mg/kg (i.p.) of arginine vasopressin, or vehicle (10%DMSO in PBS) of 20-30 minutes before testing in social behavioral paradigm(s).
Allele Type: Knockout
Strain of Origin: (129X1/SvJ x 129S1/Sv)F1-Kitl+
Genetic Background: C57BL/6J
Es cell line: R1
Model Source: Peles lab
Category | Entity | Value Change | Experimental Paradigm | Age at Testing | Author, Year |
---|---|---|---|---|---|
Circadian sleep/wake cycle | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Motor phenotype | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Neuroanatomy / ultrastructure / cytoarchitecture | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Neurophysiology | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Repetitive behavior | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Seizure | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Sensory | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Social behavior | Social interaction | Restored | Reciprocal social interaction test | 4-6 weeks | Peagarikano O , et al. (2015) |
Social behavior | Social approach | Restored | Three-chamber social approach test | 6-8 weeks | Peagarikano O , et al. (2015) |
Physiological parameters | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Communications | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Developmental profile | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Emotion | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Immune response | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Learning & memory | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Maternal behavior | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Molecular profile | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
M_CNTNAP2_5_KO_HM_AVP-2
Model Type: RESCUE-Pharmaceutical
Model Genotype: Homozygous
Mutation:
Cntnap2 KO (equal male:female ratio) juvenile (4-6 wks old) mice were administered arginine vasopressin at ~ 200ug/kg or saline intranasally 20-30 min before testing in social behavioral tests.
Allele Type: Knockout
Strain of Origin: (129X1/SvJ x 129S1/Sv)F1-Kitl+
Genetic Background: C57BL/6J
Es cell line: R1
Model Source: Peles lab
Category | Entity | Value Change | Experimental Paradigm | Age at Testing | Author, Year |
---|---|---|---|---|---|
Circadian sleep/wake cycle | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Motor phenotype | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Neuroanatomy / ultrastructure / cytoarchitecture | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Neurophysiology | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Repetitive behavior | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Seizure | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Sensory | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Social behavior | Social interaction | Restored | Reciprocal social interaction test | 4-6 weeks | Peagarikano O , et al. (2015) |
Physiological parameters | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Communications | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Developmental profile | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Emotion | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Immune response | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Learning & memory | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Maternal behavior | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Molecular profile | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
M_CNTNAP2_5_KO_HM_AVP-OXTR-ANT
Model Type: RESCUE-Pharmaceutical
Model Genotype: Homozygous
Mutation:
Cntnap2 KO (equal male:female ratio) juvenile (4-6 wks old) mice were administered with oxytocin receptor antagonist (L371,257) intranasally at a dose of 300ug/kg, followed by AVP at ~ 200ug/kg or saline intranasally 20-30 min before testing in social behavioral tests.
Allele Type: Knockout
Strain of Origin: -
Genetic Background: C57BL/6J
Es cell line: -
Model Source: -
Category | Entity | Value Change | Experimental Paradigm | Age at Testing | Author, Year |
---|---|---|---|---|---|
Circadian sleep/wake cycle | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Motor phenotype | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Neuroanatomy / ultrastructure / cytoarchitecture | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Neurophysiology | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Repetitive behavior | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Seizure | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Sensory | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Social behavior | Social interaction | Refractory | Reciprocal social interaction test | 4-6 weeks | Peagarikano O , et al. (2015) |
Physiological parameters | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Communications | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Developmental profile | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Emotion | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Immune response | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Learning & memory | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Maternal behavior | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Molecular profile | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
M_CNTNAP2_5_KO_HM_AVPR-ANT_AVP
Model Type: RESCUE-Pharmaceutical
Model Genotype: Homozygous
Mutation:
Cntnap2 KO (equal male:female ratio) juvenile (4-6 wks old) mice were administered arginine vasopressin receptor (AVP-V1a receptor)antagonist (reclovaptan) intranasally at a dose of 300ug/kg, followed by AVP at ~ 200ug/kg or saline intranasally 20-30 min before testing in social behavioral tests.
Allele Type: Knockout
Strain of Origin: (129X1/SvJ x 129S1/Sv)F1-Kitl+
Genetic Background: C57BL/6J
Es cell line: R1
Model Source: Peles lab
Category | Entity | Value Change | Experimental Paradigm | Age at Testing | Author, Year |
---|---|---|---|---|---|
Circadian sleep/wake cycle | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Motor phenotype | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Neuroanatomy / ultrastructure / cytoarchitecture | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Neurophysiology | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Repetitive behavior | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Seizure | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Sensory | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Social behavior | Social interaction | Restored | Reciprocal social interaction test | 4-6 weeks | Peagarikano O , et al. (2015) |
Physiological parameters | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Communications | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Developmental profile | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Emotion | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Immune response | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Learning & memory | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Maternal behavior | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Molecular profile | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
M_CNTNAP2_5_KO_HM_BH4
Model Type: RESCUE-Pharmaceutical
Model Genotype: Homozygous
Mutation:
Tetrahydrobiopterin dihydrochloride (bh4) was administered via oral gavage at a dose of 20 mg/kg for 2-4 weeks and 2 hours prior to behavior tests.
Allele Type: Knockout
Strain of Origin: (129X1/SvJ x 129S1/Sv)F1-Kitl+
Genetic Background: C57BL/6JÃÂ
Es cell line: R1
Model Source: C57BL/6J
Category | Entity | Value Change | Experimental Paradigm | Age at Testing | Author, Year |
---|---|---|---|---|---|
Motor phenotype | General locomotor activity: Ambulatory activity | Refractory | Three-chamber social approach test | 7-12 weeks | Buffington SA et al. (2021) |
Motor phenotype | General locomotor activity | Refractory | Three-chamber social approach test | 7-12 weeks | Buffington SA et al. (2021) |
Neurophysiology | Synaptic neuroreceptor ratio (NMDAR/AMPAR) dependent transmission | Restored | Whole-cell voltage clamp | 7-12 weeks | Buffington SA et al. (2021) |
Social behavior | Social memory | Restored | Three-chamber social approach test | 7-12 weeks | Buffington SA et al. (2021) |
Social behavior | Social interaction | Restored | Reciprocal social interaction test | 7-12 weeks | Buffington SA et al. (2021) |
Social behavior | Social approach | Restored | Three-chamber social approach test | 7-12 weeks | Buffington SA et al. (2021) |
M_CNTNAP2_5_KO_HM_C79
Model Type: RESCUE-Genetic
Model Genotype: Homozygous
Mutation:
Cntnap2 mice with two knockout alleles (MGI:2677631) were injected in the medial prefrontal cortex at the age of 3 weeks with the adeno-associated virus (AAV) vector expressing CNTNAP2-C79 protein (AAV-C79) and AAV-EGFP (as the control). C79 is the C-terminal peptide resulting from CNTNAP2 cleavage by alpha-secretase ADAM10.
Allele Type: Knockout
Strain of Origin: (129X1/SvJ x 129S1/Sv)F1-Kitl+
Genetic Background: C57BL/6J
Es cell line: R1
Model Source: Elior Peles
Category | Entity | Value Change | Experimental Paradigm | Age at Testing | Author, Year |
---|---|---|---|---|---|
Social behavior | Social interaction | Restored | Reciprocal social interaction test | 7 weeks | et al. () |
Social behavior | Social approach | Restored | Three-chamber social approach test | 7 weeks | et al. () |
Learning & memory | Spatial working memory | Restored | T-maze test | 7 weeks | et al. () |
M_CNTNAP2_5_KO_HM_COCAINE
Model Type: RESCUE-Pharmaceutical
Model Genotype: Homozygous
Mutation:
Gene targeted replacement of exon 1 of cntnap2 gene with an oppositely directed neo gene identical to model m_cntnap2_5_ko_hm. control wt c57bl/6j (stock #000664) and cntnap2 ko hm (cntnap2tm1pele, stock # 017482) (poliak et al., 2003) were obtained from jackson
Allele Type: Knockout
Strain of Origin: (129X1/SvJ x 129S1/Sv)F1-Kitl+
Genetic Background: C57BL/6J
Es cell line: R1
Model Source: C57BL/6J
Category | Entity | Value Change | Experimental Paradigm | Age at Testing | Author, Year |
---|---|---|---|---|---|
Neurophysiology | Synaptic neuroreceptor ratio (NMDAR/AMPAR) dependent transmission | Restored | Whole-cell voltage clamp | 7-12 weeks | Buffington SA et al. (2021) |
M_CNTNAP2_5_KO_HM_COHOUSING
Model Type: RESCUE-Behavioral
Model Genotype: Homozygous
Mutation:
Cntnap2 ko mutant mice originated from the isolated line were cohoused with isolated wt mice which allows the passive interchange of gut microbiota between hosts, to test the hypothesis that the social phenotype is driven by the gut microbiome and not the genetic mutation
Allele Type: Knockout
Strain of Origin: (129X1/SvJ x 129S1/Sv)F1-Kitl+
Genetic Background: C57BL/6JÃÂ
Es cell line: R1
Model Source: C57BL/6J
Category | Entity | Value Change | Experimental Paradigm | Age at Testing | Author, Year |
---|---|---|---|---|---|
Motor phenotype | General locomotor activity: Ambulatory activity | Refractory | Three-chamber social approach test | 7-12 weeks | Buffington SA et al. (2021) |
Motor phenotype | General locomotor activity | Refractory | Three-chamber social approach test | 7-12 weeks | Buffington SA et al. (2021) |
Social behavior | Social memory | Restored | Three-chamber social approach test | 7-12 weeks | Buffington SA et al. (2021) |
Social behavior | Social interaction | Restored | Reciprocal social interaction test | 7-12 weeks | Buffington SA et al. (2021) |
Social behavior | Social approach | Restored | Three-chamber social approach test | 7-12 weeks | Buffington SA et al. (2021) |
Physiological parameters | Intestinal microbiota composition | Restored | 16S rRNA gene sequence analysis for identification of bacteria | 7-12 weeks | Buffington SA et al. (2021) |
M_CNTNAP2_5_KO_HM_DREADD-OXTN
Model Type: RESCUE-Genetic
Model Genotype: Homozygous
Mutation:
Using the Designer Receptor Exclusively Activated by Designer Drug(s) (DREADD) approach a modified muscarinic receptor tagged with marker mCherry (hM3Dq-mCherry), exclusively activated by the otherwise inert ligand- clozepine N-oxide (CNO), was expressed in the oxytocin cells of the paraventricular nuclei of the hypothalamus, in Cntnap2 KO mice and wild type controls, by means of stereotaxic injection of an AAV2 virus carrying the hM3Dg-mcherry construct. The expression of hM3Dq-mCherry was restricted to oxytocin cells by driving the expression under promotor for oxytocin. CNO was administered intraperitoneally at 5mg/kg, 30 min before testing.
Allele Type: Knockout
Strain of Origin: (129X1/SvJ x 129S1/Sv)F1-Kitl+
Genetic Background: C57BL/6J
Es cell line: R1
Model Source: Peles lab
Category | Entity | Value Change | Experimental Paradigm | Age at Testing | Author, Year |
---|---|---|---|---|---|
Circadian sleep/wake cycle | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Motor phenotype | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Neuroanatomy / ultrastructure / cytoarchitecture | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Neurophysiology | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Repetitive behavior | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Seizure | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Sensory | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Social behavior | Social approach | Restored | Three-chamber social approach test | NA | Peagarikano O , et al. (2015) |
Physiological parameters | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Communications | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Developmental profile | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Emotion | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Immune response | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Learning & memory | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Maternal behavior | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Molecular profile | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
M_CNTNAP2_5_KO_HM_FENOBAM
Model Type: RESCUE-Pharmaceutical
Model Genotype: Homozygous
Mutation:
Cntnap2 KO (equal male:female ratio) juvenile (4-6 wks old) mice were acutely treated with 10 mg/kg (i.p.) of Fenobam, which is a mGlur5 agonist, or vehicle (10%DMSO in PBS) of 20-30 minutes before testing in social behavioral paradigm(s).
Allele Type: Knockout
Strain of Origin: (129X1/SvJ x 129S1/Sv)F1-Kitl+
Genetic Background: C57BL/6J
Es cell line: R1
Model Source: Peles lab
Category | Entity | Value Change | Experimental Paradigm | Age at Testing | Author, Year |
---|---|---|---|---|---|
Circadian sleep/wake cycle | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Motor phenotype | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Neuroanatomy / ultrastructure / cytoarchitecture | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Neurophysiology | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Repetitive behavior | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Seizure | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Sensory | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Social behavior | Social interaction | Refractory | Reciprocal social interaction test | 4-6 weeks | Peagarikano O , et al. (2015) |
Physiological parameters | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Communications | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Developmental profile | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Emotion | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Immune response | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Learning & memory | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Maternal behavior | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Molecular profile | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
M_CNTNAP2_5_KO_HM_FLUMAZENIL
Model Type: RESCUE-Pharmaceutical
Model Genotype: Homozygous
Mutation:
Cntnap2 KO (equal male:female ratio) juvenile (4-6 wks old) mice were acutely treated with 10 mg/kg (i.p.) of Flumazenil, which is a benzodiazepine receptor agonist , or vehicle (10%DMSO in PBS) of 20-30 minutes before testing in social behavioral paradigm(s).
Allele Type: Knockout
Strain of Origin: (129X1/SvJ x 129S1/Sv)F1-Kitl+
Genetic Background: C57BL/6J
Es cell line: R1
Model Source: Peles lab
Category | Entity | Value Change | Experimental Paradigm | Age at Testing | Author, Year |
---|---|---|---|---|---|
Circadian sleep/wake cycle | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Motor phenotype | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Neuroanatomy / ultrastructure / cytoarchitecture | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Neurophysiology | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Repetitive behavior | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Seizure | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Sensory | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Social behavior | Social interaction | Refractory | Reciprocal social interaction test | 4-6 weeks | Peagarikano O , et al. (2015) |
Physiological parameters | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Communications | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Developmental profile | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Emotion | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Immune response | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Learning & memory | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Maternal behavior | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Molecular profile | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
M_CNTNAP2_5_KO_HM_FLUOXETINE
Model Type: RESCUE-Pharmaceutical
Model Genotype: Homozygous
Mutation:
Cntnap2 KO (equal male:female ratio) juvenile (4-6 wks old) mice were acutely treated with 10 mg/kg (i.p.) of Fluoxetine, which is an serotonin reuptake inhibitor, or vehicle (10%DMSO in PBS) of 20-30 minutes before testing in social behavioral paradigm(s).
Allele Type: Knockout
Strain of Origin: (129X1/SvJ x 129S1/Sv)F1-Kitl+
Genetic Background: C57BL/6J
Es cell line: R1
Model Source: Peles lab
Category | Entity | Value Change | Experimental Paradigm | Age at Testing | Author, Year |
---|---|---|---|---|---|
Circadian sleep/wake cycle | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Motor phenotype | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Neuroanatomy / ultrastructure / cytoarchitecture | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Neurophysiology | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Repetitive behavior | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Seizure | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Sensory | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Social behavior | Social interaction | Refractory | Reciprocal social interaction test | 4-6 weeks | Peagarikano O , et al. (2015) |
Physiological parameters | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Communications | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Developmental profile | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Emotion | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Immune response | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Learning & memory | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Maternal behavior | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Molecular profile | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
M_CNTNAP2_5_KO_HM_GUT
Model Type: Multifactorial
Model Genotype: Homozygous
Mutation:
Gene targeted replacement of exon 1 of cntnap2 gene with an oppositely directed neo gene identical to model m_cntnap2_5_ko_hm. control wt c57bl/6j (stock #000664) and cntnap2 ko hm (cntnap2tm1pele, stock # 017482) (poliak et al., 2003) were obtained from jackson
Allele Type: Knockout
Strain of Origin: (129X1/SvJ x 129S1/Sv)F1-Kitl+
Genetic Background: C57BL/6J
Es cell line: R1
Model Source: C57BL/6J
Category | Entity | Value Change | Experimental Paradigm | Age at Testing | Author, Year |
---|---|---|---|---|---|
Motor phenotype | General locomotor activity: Ambulatory activity | Increased | Three-chamber social approach test | 7-12 weeks | Buffington SA et al. (2021) |
Motor phenotype | General locomotor activity | Increased | Three-chamber social approach test | 7-12 weeks | Buffington SA et al. (2021) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Neuronal number: Oxytocin expressing | Decreased | Immunofluorescence staining | 7-12 weeks | Buffington SA et al. (2021) |
Neurophysiology | Synaptic neuroreceptor ratio (NMDAR/AMPAR) dependent transmission | Decreased | Whole-cell voltage clamp | 7-12 weeks | Buffington SA et al. (2021) |
Neurophysiology | Miniature post synaptic current frequency: excitatory | Decreased | Whole-cell voltage clamp | 7-12 weeks | Buffington SA et al. (2021) |
Neurophysiology | Miniature post synaptic current amplitude: excitatory | Decreased | Whole-cell voltage clamp | 7-12 weeks | Buffington SA et al. (2021) |
Sensory | Olfaction | No change | Buried food test | 7-12 weeks | Buffington SA et al. (2021) |
Social behavior | Social memory | Decreased | Three-chamber social approach test | 7-12 weeks | Buffington SA et al. (2021) |
Social behavior | Social interaction | Decreased | Reciprocal social interaction test | 7-12 weeks | Buffington SA et al. (2021) |
Social behavior | Social approach | Decreased | Three-chamber social approach test | 7-12 weeks | Buffington SA et al. (2021) |
Physiological parameters | Intestinal microbiota composition | Abnormal | 16S rRNA gene sequence analysis for identification of bacteria | 7-12 weeks | Buffington SA et al. (2021) |
Physiological parameters | Intestinal microbiota composition | Decreased | Quantitative PCR (qRT-PCR) | 7-12 weeks | Buffington SA et al. (2021) |
Molecular profile | Metabolite level quantification | Abnormal | Liquid chromatography-mass spectrometry (LC-MS) | 7-12 weeks | Buffington SA et al. (2021) |
M_CNTNAP2_5_KO_HM_HET_BREEDING
Model Type: RESCUE-Procedural
Model Genotype: Homozygous
Mutation:
Cntnap2 ko and wt mice were generated by breeding cntnap2 ht ko mice derived by crossing cntnap2 ko hm and wt (c57bl/6j) mice obtained from jackson laboratories isolated lines to ensure intermingling of intestinal microbiota.
Allele Type: Knockout
Strain of Origin: (129X1/SvJ x 129S1/Sv)F1-Kitl+
Genetic Background: C57BL/6JÃÂ
Es cell line: R1
Model Source: C57BL/6JÃÂ
Category | Entity | Value Change | Experimental Paradigm | Age at Testing | Author, Year |
---|---|---|---|---|---|
Motor phenotype | General locomotor activity: Ambulatory activity | Refractory | Three-chamber social approach test | 7-12 weeks | Buffington SA et al. (2021) |
Motor phenotype | General locomotor activity | Refractory | Three-chamber social approach test | 7-12 weeks | Buffington SA et al. (2021) |
Social behavior | Social memory | Restored | Three-chamber social approach test | 7-12 weeks | Buffington SA et al. (2021) |
Social behavior | Social interaction | Restored | Reciprocal social interaction test | 7-12 weeks | Buffington SA et al. (2021) |
Social behavior | Social approach | Restored | Three-chamber social approach test | 7-12 weeks | Buffington SA et al. (2021) |
Physiological parameters | Intestinal microbiota composition | Restored | 16S rRNA gene sequence analysis for identification of bacteria | 7-12 weeks | Buffington SA et al. (2021) |
M_CNTNAP2_5_KO_HM_IL17A-S1DZ
Model Type: RESCUE-Pharmaceutical
Model Genotype: Homozygous
Mutation:
Recombinant IL17a protein (50 ng per side in 1 microliter at a rate of 180 nl/min, 7956-ML/CF, R&D) was administered directly and bilaterally into the primary somatosensory cortex dysgranular zone in adult male Cntnap2 mutant four hours before testing.
Allele Type: Knockout
Strain of Origin: (129X1/SvJ x 129S1/Sv)F1-Kitl+
Genetic Background: C57BL/6J
Es cell line: R1
Model Source: Peles lab
Category | Entity | Value Change | Experimental Paradigm | Age at Testing | Author, Year |
---|---|---|---|---|---|
Circadian sleep/wake cycle | NA | Not reported | NA | NA | () |
Motor phenotype | NA | Not reported | NA | NA | () |
Neuroanatomy / ultrastructure / cytoarchitecture | NA | Not reported | NA | NA | () |
Neurophysiology | NA | Not reported | NA | NA | () |
Repetitive behavior | NA | Not reported | NA | NA | () |
Seizure | NA | Not reported | NA | NA | () |
Sensory | NA | Not reported | NA | NA | () |
Social behavior | Social approach | Restored | Three-chamber social approach test | Adult | () |
Physiological parameters | NA | Not reported | NA | NA | () |
Communications | NA | Not reported | NA | NA | () |
Developmental profile | NA | Not reported | NA | NA | () |
Emotion | NA | Not reported | NA | NA | () |
Immune response | NA | Not reported | NA | NA | () |
Learning & memory | NA | Not reported | NA | NA | () |
Maternal behavior | NA | Not reported | NA | NA | () |
Molecular profile | NA | Not reported | NA | NA | () |
M_CNTNAP2_5_KO_HM_LPS
Model Type: RESCUE-Pharmaceutical
Model Genotype: Homozygous
Mutation:
Cntnap2 homozygous mutants were treated with lipopolysaccharide (50microgram/kg, i.p., acute)
Allele Type: Knockout
Strain of Origin: (129X1/SvJ x 129S1/Sv)F1-Kitl+
Genetic Background: C57BL/6J
Es cell line: R1
Model Source: Peles lab
Category | Entity | Value Change | Experimental Paradigm | Age at Testing | Author, Year |
---|---|---|---|---|---|
Circadian sleep/wake cycle | NA | Not reported | NA | NA | () |
Motor phenotype | NA | Not reported | NA | NA | () |
Neuroanatomy / ultrastructure / cytoarchitecture | NA | Not reported | NA | NA | () |
Neurophysiology | Neuronal activation | Refractory | Immunohistochemistry | Adult | () |
Repetitive behavior | NA | Not reported | NA | NA | () |
Seizure | NA | Not reported | NA | NA | () |
Sensory | NA | Not reported | NA | NA | () |
Social behavior | Social approach | Refractory | Three-chamber social approach test | Adult | () |
Physiological parameters | NA | Not reported | NA | NA | () |
Communications | NA | Not reported | NA | NA | () |
Developmental profile | NA | Not reported | NA | NA | () |
Emotion | NA | Not reported | NA | NA | () |
Immune response | Cytokine levels: pro-inflammatory | Side effect | Elisa | Adult, 2-5 months, 9-12 months | () |
Learning & memory | NA | Not reported | NA | NA | () |
Maternal behavior | NA | Not reported | NA | NA | () |
Molecular profile | NA | Not reported | NA | NA | () |
M_CNTNAP2_5_KO_HM_LREUTERI
Model Type: RESCUE-Dietary
Model Genotype: Homozygous
Mutation:
L. reuteri was added to the drinking water daily to minimize dosage variability. the experimental group received live bacteria (approximately 10^8 organisms/mouse/day), while the control group received equal volume of pbs. mice drank the treated water ad libitum during the treatment period. fecal sample collection, behavioral assays, tissue collection and electrophysiological recordings were initiated 4 weeks after the beginning of the treatment period.
Allele Type: Knockout
Strain of Origin: (129X1/SvJ x 129S1/Sv)F1-Kitl+
Genetic Background: C57BL/6JÃÂ
Es cell line: R1
Model Source: C57BL/6JÃÂ
Category | Entity | Value Change | Experimental Paradigm | Age at Testing | Author, Year |
---|---|---|---|---|---|
Motor phenotype | General locomotor activity: Ambulatory activity | Refractory | Three-chamber social approach test | 7-12 weeks, Adult | Buffington SA et al. (2021) |
Motor phenotype | General locomotor activity | Refractory | Three-chamber social approach test | 7-12 weeks, Adult | Buffington SA et al. (2021) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Neuronal number: Oxytocin expressing | Restored | Immunofluorescence staining | 7-12 weeks | Buffington SA et al. (2021) |
Neurophysiology | Synaptic neuroreceptor ratio (NMDAR/AMPAR) dependent transmission | Restored | Whole-cell voltage clamp | 7-12 weeks | Buffington SA et al. (2021) |
Neurophysiology | Miniature post synaptic current frequency: excitatory | Refractory | Whole-cell voltage clamp | 7-12 weeks | Buffington SA et al. (2021) |
Neurophysiology | Miniature post synaptic current amplitude: excitatory | Refractory | Whole-cell voltage clamp | 7-12 weeks | Buffington SA et al. (2021) |
Social behavior | Social memory | Restored | Three-chamber social approach test | 7-12 weeks, Adult | Buffington SA et al. (2021) |
Social behavior | Social interaction | Restored | Reciprocal social interaction test | 7-12 weeks, Adult | Buffington SA et al. (2021) |
Social behavior | Social approach | Restored | Three-chamber social approach test | 7-12 weeks, Adult | Buffington SA et al. (2021) |
Molecular profile | Metabolite level quantification | Ameliorates | Liquid chromatography-mass spectrometry (LC-MS) | 7-12 weeks | Buffington SA et al. (2021) |
M_CNTNAP2_5_KO_HM_MC4R-AG
Model Type: RESCUE-Pharmaceutical
Model Genotype: Homozygous
Mutation:
Cntnap2 KO (equal male:female ratio) juvenile (4-6 wks old) mice were administered MC4R agonist at 7.5 mg/kg (i.p.) 20-30 min before testing in social behavioral tests.
Allele Type: Knockout
Strain of Origin: (129X1/SvJ x 129S1/Sv)F1-Kitl+
Genetic Background: C57BL/6J
Es cell line: R1
Model Source: Peles lab
Category | Entity | Value Change | Experimental Paradigm | Age at Testing | Author, Year |
---|---|---|---|---|---|
Circadian sleep/wake cycle | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Motor phenotype | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Neuroanatomy / ultrastructure / cytoarchitecture | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Neurophysiology | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Repetitive behavior | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Seizure | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Sensory | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Social behavior | Social interaction | Restored | Reciprocal social interaction test | 4-6 weeks | Peagarikano O , et al. (2015) |
Physiological parameters | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Communications | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Developmental profile | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Emotion | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Immune response | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Learning & memory | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Maternal behavior | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Molecular profile | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
M_CNTNAP2_5_KO_HM_MC4R-AG-OXTR-ANT
Model Type: RESCUE-Pharmaceutical
Model Genotype: Homozygous
Mutation:
Cntnap2 KO (equal male:female ratio) juvenile (4-6 wks old) mice were administered OXTR antagonist (L371,257) intranasally at 300ug/kg, followed by MC4R agonist at 7.5 mg/kg (i.p.), followed by 20-30 min before testing in social behavioral tests.
Allele Type: Knockout
Strain of Origin: -
Genetic Background: C57BL/6J
Es cell line: -
Model Source: -
Category | Entity | Value Change | Experimental Paradigm | Age at Testing | Author, Year |
---|---|---|---|---|---|
Circadian sleep/wake cycle | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Motor phenotype | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Neuroanatomy / ultrastructure / cytoarchitecture | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Neurophysiology | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Repetitive behavior | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Seizure | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Sensory | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Social behavior | Social interaction | Refractory | Reciprocal social interaction test | 4-6 weeks | Peagarikano O , et al. (2015) |
Physiological parameters | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Communications | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Developmental profile | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Emotion | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Immune response | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Learning & memory | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Maternal behavior | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Molecular profile | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
M_CNTNAP2_5_KO_HM_OXT-OXTR-ANT
Model Type: RESCUE-Pharmaceutical
Model Genotype: Homozygous
Mutation:
Cntnap2 KO (equal male:female ratio) juvenile (4-6 wks old) mice were administered an oxytocin receptor antagonist (L371,257) intranasally at a dose of 300ug/kg, followed by oxytocin at ~ 200ug/kg or saline intranasally 20-30 min before testing in social behavioral tests.
Allele Type: Knockout
Strain of Origin: -
Genetic Background: C57BL/6J
Es cell line: -
Model Source: -
Category | Entity | Value Change | Experimental Paradigm | Age at Testing | Author, Year |
---|---|---|---|---|---|
Circadian sleep/wake cycle | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Motor phenotype | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Neuroanatomy / ultrastructure / cytoarchitecture | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Neurophysiology | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Repetitive behavior | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Seizure | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Sensory | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Social behavior | Social interaction | Refractory | Reciprocal social interaction test | 4-6 weeks | Peagarikano O , et al. (2015) |
Physiological parameters | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Communications | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Developmental profile | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Emotion | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Immune response | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Learning & memory | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Maternal behavior | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Molecular profile | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
M_CNTNAP2_5_KO_HM_OXTR-ANT_AVP
Model Type: RESCUE-Pharmaceutical
Model Genotype: Homozygous
Mutation:
Cntnap2 KO (equal male:female ratio) juvenile (4-6 wks old) mice were administered with oxytocin receptor antagonist (L371,257) intranasally at a dose of 300ug/kg, followed by AVP at ~ 200ug/kg or saline intranasally 20-30 min before testing in social behavioral tests.
Allele Type: Knockout
Strain of Origin: (129X1/SvJ x 129S1/Sv)F1-Kitl+
Genetic Background: C57BL/6J
Es cell line: R1
Model Source: Peles lab
Category | Entity | Value Change | Experimental Paradigm | Age at Testing | Author, Year |
---|---|---|---|---|---|
Circadian sleep/wake cycle | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Motor phenotype | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Neuroanatomy / ultrastructure / cytoarchitecture | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Neurophysiology | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Repetitive behavior | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Seizure | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Sensory | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Social behavior | Social interaction | Refractory | Reciprocal social interaction test | 4-6 weeks | Peagarikano O , et al. (2015) |
Physiological parameters | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Communications | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Developmental profile | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Emotion | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Immune response | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Learning & memory | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Maternal behavior | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Molecular profile | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
M_CNTNAP2_5_KO_HM_OXTR-ANT_MC4R-AG
Model Type: RESCUE-Pharmaceutical
Model Genotype: Homozygous
Mutation:
Cntnap2 KO (equal male:female ratio) juvenile (4-6 wks old) mice were administered OXTR antagonist (L371,257) intranasally at 300ug/kg, followed by MC4R agonist at 7.5 mg/kg (i.p.), followed by 20-30 min before testing in social behavioral tests.
Allele Type: Knockout
Strain of Origin: (129X1/SvJ x 129S1/Sv)F1-Kitl+
Genetic Background: C57BL/6J
Es cell line: R1
Model Source: Peles lab
Category | Entity | Value Change | Experimental Paradigm | Age at Testing | Author, Year |
---|---|---|---|---|---|
Circadian sleep/wake cycle | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Motor phenotype | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Neuroanatomy / ultrastructure / cytoarchitecture | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Neurophysiology | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Repetitive behavior | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Seizure | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Sensory | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Social behavior | Social interaction | Refractory | Reciprocal social interaction test | 4-6 weeks | Peagarikano O , et al. (2015) |
Physiological parameters | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Communications | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Developmental profile | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Emotion | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Immune response | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Learning & memory | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Maternal behavior | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Molecular profile | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
M_CNTNAP2_5_KO_HM_OXTR-ANT_OXT
Model Type: RESCUE-Pharmaceutical
Model Genotype: Homozygous
Mutation:
Cntnap2 KO (equal male:female ratio) juvenile (4-6 wks old) mice were administered an oxytocin receptor antagonist (L371,257) intranasally at a dose of 300ug/kg, followed by oxytocin at ~ 200ug/kg or saline intranasally 20-30 min before testing in social behavioral tests.
Allele Type: Knockout
Strain of Origin: (129X1/SvJ x 129S1/Sv)F1-Kitl+
Genetic Background: C57BL/6J
Es cell line: R1
Model Source: Peles lab
Category | Entity | Value Change | Experimental Paradigm | Age at Testing | Author, Year |
---|---|---|---|---|---|
Circadian sleep/wake cycle | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Motor phenotype | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Neuroanatomy / ultrastructure / cytoarchitecture | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Neurophysiology | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Repetitive behavior | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Seizure | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Sensory | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Social behavior | Social interaction | Refractory | Reciprocal social interaction test | 4-6 weeks | Peagarikano O , et al. (2015) |
Physiological parameters | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Communications | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Developmental profile | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Emotion | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Immune response | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Learning & memory | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Maternal behavior | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Molecular profile | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
M_CNTNAP2_5_KO_HM_OXYTOCIN
Model Type: RESCUE-Pharmaceutical
Model Genotype: Homozygous
Mutation:
Oxytocin was administrated intranasally at a dose of 200 mg/kg 30 minutes prior to social behavior testing, since the effects of oxytocin last 2 hours with this delivery method.
Allele Type: Knockout
Strain of Origin: (129X1/SvJ x 129S1/Sv)F1-Kitl+
Genetic Background: C57BL/6JÃÂ
Es cell line: R1
Model Source: C57BL/6JÃÂ
Category | Entity | Value Change | Experimental Paradigm | Age at Testing | Author, Year |
---|---|---|---|---|---|
Motor phenotype | General locomotor activity: Ambulatory activity | Refractory | Three-chamber social approach test | 7-12 weeks | Buffington SA et al. (2021) |
Motor phenotype | General locomotor activity | Refractory | Three-chamber social approach test | 7-12 weeks | Buffington SA et al. (2021) |
Social behavior | Social memory | Restored | Three-chamber social approach test | 7-12 weeks | Buffington SA et al. (2021) |
Social behavior | Social interaction | Restored | Reciprocal social interaction test | 7-12 weeks | Buffington SA et al. (2021) |
Social behavior | Social approach | Restored | Three-chamber social approach test | 7-12 weeks | Buffington SA et al. (2021) |
M_CNTNAP2_5_KO_HM_OXYTOCIN-1
Model Type: RESCUE-Pharmaceutical
Model Genotype: Homozygous
Mutation:
Cntnap2 KO (equal male:female ratio) juvenile (4-6 wks old) mice were acutely treated with 10 mg/kg (i.p.)of oxytocin, or vehicle (10%DMSO in PBS) of 20-30 minutes before testing in social behavioral paradigm(s).
Allele Type: Knockout
Strain of Origin: (129X1/SvJ x 129S1/Sv)F1-Kitl+
Genetic Background: C57BL/6J
Es cell line: R1
Model Source: Peles lab
Category | Entity | Value Change | Experimental Paradigm | Age at Testing | Author, Year |
---|---|---|---|---|---|
Circadian sleep/wake cycle | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Motor phenotype | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Neuroanatomy / ultrastructure / cytoarchitecture | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Neurophysiology | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Repetitive behavior | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Seizure | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Sensory | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Social behavior | Social interaction | Restored | Reciprocal social interaction test | 4-6 weeks | Peagarikano O , et al. (2015) |
Social behavior | Social approach | Restored | Three-chamber social approach test | 6-8 weeks | Peagarikano O , et al. (2015) |
Physiological parameters | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Communications | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Developmental profile | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Emotion | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Immune response | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Learning & memory | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Maternal behavior | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Molecular profile | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
M_CNTNAP2_5_KO_HM_OXYTOCIN-2
Model Type: RESCUE-Pharmaceutical
Model Genotype: Homozygous
Mutation:
Cntnap2 KO (equal male:female ratio) juvenile (4-6 wks old) mice were administered oxytocin at ~ 200ug/kg or saline intranasally 20-30 min before testing in social behavioral tests.A group of these animals were also tested a 1-9 hrs after drug administration.
Allele Type: Knockout
Strain of Origin: (129X1/SvJ x 129S1/Sv)F1-Kitl+
Genetic Background: C57BL/6J
Es cell line: R1
Model Source: Peles lab
Category | Entity | Value Change | Experimental Paradigm | Age at Testing | Author, Year |
---|---|---|---|---|---|
Circadian sleep/wake cycle | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Motor phenotype | Hyperactivity | Refractory | Open field test | 4-6 weeks | Peagarikano O , et al. (2015) |
Neuroanatomy / ultrastructure / cytoarchitecture | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Neurophysiology | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Repetitive behavior | Self grooming: perseveration | Refractory | Grooming behavior assessments | 4-6 weeks | Peagarikano O , et al. (2015) |
Seizure | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Sensory | Pain or nociception | Refractory | Hot plate test | 4-6 weeks | Peagarikano O , et al. (2015) |
Social behavior | Social interaction | Restored | Reciprocal social interaction test | 4-6 weeks | Peagarikano O , et al. (2015) |
Physiological parameters | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Communications | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Developmental profile | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Emotion | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Immune response | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Learning & memory | Spatial working memory | Refractory | T-maze test | 4-6 weeks | Peagarikano O , et al. (2015) |
Maternal behavior | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Molecular profile | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
M_CNTNAP2_5_KO_HM_OXYTOCIN-3
Model Type: RESCUE-Pharmaceutical
Model Genotype: Homozygous
Mutation:
Cntnap2 KO pups were treated with a daily administration of oxytocin at ~ 200ug/kg or saline intranasally between {P7- P21 and tested at P30.
Allele Type: Knockout
Strain of Origin: (129X1/SvJ x 129S1/Sv)F1-Kitl+
Genetic Background: C57BL/6J
Es cell line: R1
Model Source: Peles lab
Category | Entity | Value Change | Experimental Paradigm | Age at Testing | Author, Year |
---|---|---|---|---|---|
Circadian sleep/wake cycle | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Motor phenotype | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Neuronal number: oxytocin expressing | Ameliorated | Immunohistochemistry | 4 weeks | Peagarikano O , et al. (2015) |
Neurophysiology | Neurotransmitter release: neurohypophysial | Ameliorated | Radioimmunoassay (ria) | 4 weeks | Peagarikano O , et al. (2015) |
Repetitive behavior | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Seizure | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Sensory | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Social behavior | Social interaction | Restored | Reciprocal social interaction test | 4 weeks | Peagarikano O , et al. (2015) |
Social behavior | Social approach | Restored | Three-chamber social approach test | 4 weeks | Peagarikano O , et al. (2015) |
Physiological parameters | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Communications | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Developmental profile | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Emotion | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Immune response | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Learning & memory | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Maternal behavior | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
Molecular profile | NA | Not reported | NA | NA | Peagarikano O , et al. (2015) |
M_CNTNAP2_5_KO_HM_PV
Model Type: RESCUE-Procedural
Model Genotype: Homozygous
Mutation:
Cntnap2 null mutant mice with a temporally precise reduction in E:I balance in the medial prefrontal cortex (mPFC) generated by optogenetically increasing the excitability of inhibitory parvalbumin (PV) neurons in a real-time and reversible manner. PV:Cre homozygous mice were bred with cntnap2 KO male mice for several generations to obtain PV:Cre homozygous, Cntnap2 wildtype, heterozygous and null mice. AAV5-EF1a::DIO-SSFO-eYFP was injected into the medial prefrontal cortex to selectively express the microbial stabilized step-function opsin (SSFO) in mouse parvalbumin neurons. Activation of SSFO in PV neurons by a single pulse of blue light (2 second light pulse of wavelength 473 nm) resulted in the neurons requiring lower inward-current amplitudes to generate action potentials. This indicated SSFO activation increased the excitability of the inhibitory PV neurons.
Allele Type: Knockout
Strain of Origin: (129X1/SvJ x 129S1/Sv)F1-Kitl+
Genetic Background: C57BL/6J
Es cell line: R1
Model Source: Peles lab
Category | Entity | Value Change | Experimental Paradigm | Age at Testing | Author, Year |
---|---|---|---|---|---|
Circadian sleep/wake cycle | NA | Not reported | NA | NA | Selimbeyoglu A , et al. (2017) |
Motor phenotype | Spontaneous movement | Restored | Open field test | Adult | Selimbeyoglu A , et al. (2017) |
Motor phenotype | General locomotor activity | Restored | Reciprocal social interaction test | Adult | Selimbeyoglu A , et al. (2017) |
Neuroanatomy / ultrastructure / cytoarchitecture | NA | Not reported | NA | NA | Selimbeyoglu A , et al. (2017) |
Neurophysiology | Neuronal activation | Ameliorated | Fiber photometry | Adult | Selimbeyoglu A , et al. (2017) |
Repetitive behavior | NA | Not reported | NA | NA | Selimbeyoglu A , et al. (2017) |
Seizure | NA | Not reported | NA | NA | Selimbeyoglu A , et al. (2017) |
Sensory | NA | Not reported | NA | NA | Selimbeyoglu A , et al. (2017) |
Social behavior | Social interaction | Restored | Reciprocal social interaction test | Adult | Selimbeyoglu A , et al. (2017) |
Social behavior | Inanimate object preference | Ameliorated | Novel object recognition test | Adult | Selimbeyoglu A , et al. (2017) |
Physiological parameters | NA | Not reported | NA | NA | Selimbeyoglu A , et al. (2017) |
Communications | NA | Not reported | NA | NA | Selimbeyoglu A , et al. (2017) |
Developmental profile | NA | Not reported | NA | NA | Selimbeyoglu A , et al. (2017) |
Emotion | NA | Not reported | NA | NA | Selimbeyoglu A , et al. (2017) |
Immune response | NA | Not reported | NA | NA | Selimbeyoglu A , et al. (2017) |
Learning & memory | NA | Not reported | NA | NA | Selimbeyoglu A , et al. (2017) |
Maternal behavior | NA | Not reported | NA | NA | Selimbeyoglu A , et al. (2017) |
Molecular profile | NA | Not reported | NA | NA | Selimbeyoglu A , et al. (2017) |
M_CNTNAP2_5_KO_HM_PY
Model Type: RESCUE-Procedural
Model Genotype: Homozygous
Mutation:
Cntnap2 null mutant mice with a temporally precise reduction in E:I balance in the medial prefrontal cortex (mPFC) by optogenetically decreasing the excitability of excitatory pyramidal neurons in a real-time and reversible manner. SwiChR++, a blue lightactivated bistable chloride channel, was selectively expressed in excitatory pyramidal neurons by injection of AAV8-CKIIa-SwiChR++-eYFP into the medial prefrontal cortex.1 second pulses of 473-nm wavelength light at 1-min intervals were used to activate SwiChR++.
Allele Type: Knockout
Strain of Origin: (129X1/SvJ x 129S1/Sv)F1-Kitl+
Genetic Background: C57BL/6J
Es cell line: R1
Model Source: Peles lab
Category | Entity | Value Change | Experimental Paradigm | Age at Testing | Author, Year |
---|---|---|---|---|---|
Circadian sleep/wake cycle | NA | Not reported | NA | NA | Selimbeyoglu A , et al. (2017) |
Motor phenotype | Spontaneous movement | Restored | Open field test | Adult | Selimbeyoglu A , et al. (2017) |
Motor phenotype | General locomotor activity | Restored | Reciprocal social interaction test | Adult | Selimbeyoglu A , et al. (2017) |
Neuroanatomy / ultrastructure / cytoarchitecture | NA | Not reported | NA | NA | Selimbeyoglu A , et al. (2017) |
Neurophysiology | NA | Not reported | NA | NA | Selimbeyoglu A , et al. (2017) |
Repetitive behavior | NA | Not reported | NA | NA | Selimbeyoglu A , et al. (2017) |
Seizure | NA | Not reported | NA | NA | Selimbeyoglu A , et al. (2017) |
Sensory | NA | Not reported | NA | NA | Selimbeyoglu A , et al. (2017) |
Social behavior | Social interaction | Ameliorated | Reciprocal social interaction test | Adult | Selimbeyoglu A , et al. (2017) |
Social behavior | Inanimate object preference | Ameliorated | Novel object recognition test | Adult | Selimbeyoglu A , et al. (2017) |
Physiological parameters | NA | Not reported | NA | NA | Selimbeyoglu A , et al. (2017) |
Communications | NA | Not reported | NA | NA | Selimbeyoglu A , et al. (2017) |
Developmental profile | NA | Not reported | NA | NA | Selimbeyoglu A , et al. (2017) |
Emotion | NA | Not reported | NA | NA | Selimbeyoglu A , et al. (2017) |
Immune response | NA | Not reported | NA | NA | Selimbeyoglu A , et al. (2017) |
Learning & memory | NA | Not reported | NA | NA | Selimbeyoglu A , et al. (2017) |
Maternal behavior | NA | Not reported | NA | NA | Selimbeyoglu A , et al. (2017) |
Molecular profile | NA | Not reported | NA | NA | Selimbeyoglu A , et al. (2017) |
M_CNTNAP2_5_KO_HM_RISPERIDONE
Model Type: RESCUE-Pharmaceutical
Model Genotype: Homozygous
Mutation:
Cntnap2 KO mice were treated with risperidone or vehicle for 7-10 days.
Allele Type: Knockout
Strain of Origin: (129X1/SvJ x 129S1/Sv)F1-Kitl+
Genetic Background: C57BL/6J
Es cell line: R1
Model Source: Peles lab
Category | Entity | Value Change | Experimental Paradigm | Age at Testing | Author, Year |
---|---|---|---|---|---|
Circadian sleep/wake cycle | NA | Not reported | NA | NA | Peagarikano O , et al. (2011) |
Motor phenotype | General locomotor activity | Restored | Open field test | NA | Peagarikano O , et al. (2011) |
Neuroanatomy / ultrastructure / cytoarchitecture | NA | Not reported | NA | NA | Peagarikano O , et al. (2011) |
Neurophysiology | NA | Not reported | NA | NA | Peagarikano O , et al. (2011) |
Repetitive behavior | Perseveration | Restored | T-maze test | NA | Peagarikano O , et al. (2011) |
Seizure | NA | Not reported | NA | NA | Peagarikano O , et al. (2011) |
Sensory | Pain or nociception | Refractory | Hot plate test | NA | Peagarikano O , et al. (2011) |
Social behavior | Social interaction | Refractory | Three-chamber social approach test | Unreported | Peagarikano O , et al. (2011) |
Social behavior | Nest building behavior | Restored | General observations | NA | Peagarikano O , et al. (2011) |
Physiological parameters | NA | Not reported | NA | NA | Peagarikano O , et al. (2011) |
Communications | NA | Not reported | NA | NA | Peagarikano O , et al. (2011) |
Developmental profile | NA | Not reported | NA | NA | Peagarikano O , et al. (2011) |
Emotion | NA | Not reported | NA | NA | Peagarikano O , et al. (2011) |
Immune response | NA | Not reported | NA | NA | Peagarikano O , et al. (2011) |
Learning & memory | Object recognition memory | Restored | General observations | Unreported | Peagarikano O , et al. (2011) |
Maternal behavior | NA | Not reported | NA | NA | Peagarikano O , et al. (2011) |
Molecular profile | NA | Not reported | NA | NA | Peagarikano O , et al. (2011) |
M_CNTNAP2_5_KO_HM_S1DZ-INACT
Model Type: RESCUE-Procedural
Model Genotype: Homozygous
Mutation:
Neural activity was optogenetically suppressed in the primary somatosensory cortex dysgranular zone in Cntnap2 mutant mice. Control mice express enhanced yellow fluorescent protein (EYFP).
Allele Type: Knockout
Strain of Origin: (129X1/SvJ x 129S1/Sv)F1-Kitl+
Genetic Background: C57BL/6J
Es cell line: R1
Model Source: Peles lab
Category | Entity | Value Change | Experimental Paradigm | Age at Testing | Author, Year |
---|---|---|---|---|---|
Circadian sleep/wake cycle | NA | Not reported | NA | NA | () |
Motor phenotype | NA | Not reported | NA | NA | () |
Neuroanatomy / ultrastructure / cytoarchitecture | NA | Not reported | NA | NA | () |
Neurophysiology | NA | Not reported | NA | NA | () |
Repetitive behavior | NA | Not reported | NA | NA | () |
Seizure | NA | Not reported | NA | NA | () |
Sensory | NA | Not reported | NA | NA | () |
Social behavior | Social approach | Restored | Three-chamber social approach test | Adult | () |
Physiological parameters | NA | Not reported | NA | NA | () |
Communications | NA | Not reported | NA | NA | () |
Developmental profile | NA | Not reported | NA | NA | () |
Emotion | NA | Not reported | NA | NA | () |
Immune response | NA | Not reported | NA | NA | () |
Learning & memory | NA | Not reported | NA | NA | () |
Maternal behavior | NA | Not reported | NA | NA | () |
Molecular profile | NA | Not reported | NA | NA | () |
M_CNTNAP2_5_KO_HM_TAU-DEF-1
Model Type: RESCUE-Genetic
Model Genotype: Homozygous
Mutation:
Cntnap2 null mice (M_CNTNAP2_5_KO_HM) and controls were crossed onto heterozygous MAPT (rescue) backgrounds (Gheyara et al., 2014) that impart 50% brain tau levels compared to Mapt wildtype controls.
Allele Type: Knockout
Strain of Origin: (129X1/SvJ x 129S1/Sv)F1-Kitl+
Genetic Background: C57BL/6J
Es cell line: R1
Model Source: Peles lab
Category | Entity | Value Change | Experimental Paradigm | Age at Testing | Author, Year |
---|---|---|---|---|---|
Neuroanatomy / Ultrastructure / Cytoarchitecture | Brain size | Restored | Measurement of tissue weight | 9-10 months | Tai C et al. (2020) |
Repetitive behavior | Self grooming: perseveration | Restored | Novel cage test | 3-4 months | Tai C et al. (2020) |
Seizure | Electroencephalogram (eeg): signature of seizure/epilepsy | Restored | Electroencephalogram (eeg) | 7-11 months | Tai C et al. (2020) |
Social behavior | Nest building behavior | Restored | Nest building assay | 7-11 months | Tai C et al. (2020) |
Communications | Ultrasonic vocalization: isolation induced | Restored | Monitoring ultrasonic vocalizations | P5 | Tai C et al. (2020) |
M_CNTNAP2_5_KO_HM_TAU-DEF-2
Model Type: RESCUE-Genetic
Model Genotype: Homozygous
Mutation:
Cntnap2 null mice (M_CNTNAP2_5_KO_HM) and controls were crossed onto null MAPT (rescue) backgrounds (Gheyara et al., 2014) that impart 0% brain tau levels compared to Mapt wildtype controls.
Allele Type: Knockout
Strain of Origin: (129X1/SvJ x 129S1/Sv)F1-Kitl+
Genetic Background: C57BL/6J
Es cell line: R1
Model Source: Peles lab
Category | Entity | Value Change | Experimental Paradigm | Age at Testing | Author, Year |
---|---|---|---|---|---|
Neuroanatomy / Ultrastructure / Cytoarchitecture | Brain size | Restored | Measurement of tissue weight | 9-10 months | Tai C et al. (2020) |
Repetitive behavior | Self grooming: perseveration | Restored | Novel cage test | 3-4 months | Tai C et al. (2020) |
Seizure | Electroencephalogram (eeg): signature of seizure/epilepsy | Restored | Electroencephalogram (eeg) | 7-11 months | Tai C et al. (2020) |
Social behavior | Social scent marking or recognition | Restored | Olfactory habituation-dishabituation test | 7-11 months | Tai C et al. (2020) |
Social behavior | Nest building behavior | Restored | Nest building assay | 7-11 months | Tai C et al. (2020) |
Communications | Ultrasonic vocalization: isolation induced | Restored | Monitoring ultrasonic vocalizations | P5 | Tai C et al. (2020) |
Learning & memory | Olfactory learning and memory | No adverse effect | Olfactory habituation-dishabituation test | 7-11 months | Tai C et al. (2020) |
Molecular profile | Signaling: pi3k/akt pathway | Restored | Western blot | 6-7 months | Tai C et al. (2020) |
Molecular profile | Signaling: mtor pathway | Restored | Western blot | 6-7 months | Tai C et al. (2020) |
M_CNTNAP2_5_KO_HM_WT-LITTER-SEPARATION
Model Type: RESCUE-Behavioral
Model Genotype: Homozygous
Mutation:
Cntnap2 ko mutant mice originated from the littermate line were separated from wildtype littermates to test the hypothesis that the social phenotype is driven by the gut microbiome and not the genetic mutation. to accomplish this wt and ko littermate mice were separated according to their genotype at weaning and bred as adults to generate transgenerational wt and ko mice (wt-t and ko-t)
Allele Type: Knockout
Strain of Origin: (129X1/SvJ x 129S1/Sv)F1-Kitl+
Genetic Background: C57BL/6JÃÂ
Es cell line: R1
Model Source: C57BL/6JÃÂ
Category | Entity | Value Change | Experimental Paradigm | Age at Testing | Author, Year |
---|---|---|---|---|---|
Motor phenotype | General locomotor activity: Ambulatory activity | Refractory | Three-chamber social approach test | 7-12 weeks | Buffington SA et al. (2021) |
Motor phenotype | General locomotor activity | Refractory | Three-chamber social approach test | 7-12 weeks | Buffington SA et al. (2021) |
Social behavior | Social memory | Refractory | Three-chamber social approach test | 7-12 weeks | Buffington SA et al. (2021) |
Social behavior | Social interaction | Refractory | Reciprocal social interaction test | 7-12 weeks | Buffington SA et al. (2021) |
Social behavior | Social approach | Restored | Three-chamber social approach test | 7-12 weeks | Buffington SA et al. (2021) |
Physiological parameters | Intestinal microbiota composition | Refractory | 16S rRNA gene sequence analysis for identification of bacteria | 7-12 weeks | Buffington SA et al. (2021) |
M_CNTNAP2_6_KO_HT
Model Type: Genetic
Model Genotype: Heterozygous
Mutation:
Targeted replacement of exon 1 of Cntnap2 gene maintained as a heterozygous.
Allele Type: Knockout
Strain of Origin: (129X1/SvJ x 129S1/Sv)F1-Kitl+
Genetic Background: C57BL/6J
Es cell line: R1
Model Source: Peles lab
Category | Entity | Value Change | Experimental Paradigm | Age at Testing | Author, Year |
---|---|---|---|---|---|
Circadian sleep/wake cycle | NA | Not reported | NA | NA | - |
Circadian sleep/wake cycle | NA | Not reported | NA | NA | Antoine MW , et al. (2019) |
Circadian sleep/wake cycle | NA | Not reported | NA | NA | Kloth AD , et al. (2015) |
Circadian sleep/wake cycle | NA | Not reported | NA | NA | Peagarikano O , et al. (2011) |
Motor phenotype | NA | Not reported | NA | NA | - |
Motor phenotype | NA | Not reported | NA | NA | Antoine MW , et al. (2019) |
Motor phenotype | NA | Not reported | NA | NA | Kloth AD , et al. (2015) |
Motor phenotype | Motor coordination and balance | No change | Accelerating rotarod test | NA | Peagarikano O , et al. (2011) |
Motor phenotype | General locomotor activity: ambulatory activity | No change | Open field test | NA | Peagarikano O , et al. (2011) |
Neuroanatomy / ultrastructure / cytoarchitecture | NA | Not reported | NA | NA | - |
Neuroanatomy / ultrastructure / cytoarchitecture | NA | Not reported | NA | NA | Antoine MW , et al. (2019) |
Neuroanatomy / ultrastructure / cytoarchitecture | NA | Not reported | NA | NA | Kloth AD , et al. (2015) |
Neuroanatomy / ultrastructure / cytoarchitecture | NA | Not reported | NA | NA | Peagarikano O , et al. (2011) |
Neurophysiology | Neuronal activation | No change | Whole-cell voltage clamp | P17-p23 | - |
Neurophysiology | Synaptic transmission | Increased | Whole-cell voltage clamp | P17-p23 | Antoine MW , et al. (2019) |
Neurophysiology | Stimulus-spike relationship: inhibitory | Decreased | Whole-cell voltage clamp | P17-p23 | Antoine MW , et al. (2019) |
Neurophysiology | Spontaneous post synaptic event frequency: inhibitory currents | Decreased | Whole-cell voltage clamp | P17-p23 | Antoine MW , et al. (2019) |
Neurophysiology | Spontaneous post synaptic event frequency: excitatory currents | Decreased | Whole-cell voltage clamp | P17-p23 | Antoine MW , et al. (2019) |
Neurophysiology | Spontaneous post synaptic event amplitude: inhibitory currents | No change | Whole-cell voltage clamp | P17-p23 | Antoine MW , et al. (2019) |
Neurophysiology | Spontaneous post synaptic event amplitude: excitatory currents | No change | Whole-cell voltage clamp | P17-p23 | Antoine MW , et al. (2019) |
Neurophysiology | Network excitability | No change | Whole-cell voltage clamp | P17-p23 | Antoine MW , et al. (2019) |
Neurophysiology | Network excitability | No change | Whole-cell current clamp | P17-p23 | Antoine MW , et al. (2019) |
Neurophysiology | Membrane potential | No change | Whole-cell voltage clamp | P17-p23 | Antoine MW , et al. (2019) |
Neurophysiology | Intrinsic membrane properties | No change | Whole-cell voltage clamp | P17-p23 | Antoine MW , et al. (2019) |
Neurophysiology | Epsp-spike relationship | Decreased | Whole-cell voltage clamp | P17-p23 | Antoine MW , et al. (2019) |
Neurophysiology | Decay kinetics of miniature post synaptic currents | No change | Whole-cell voltage clamp | P17-p23 | Antoine MW , et al. (2019) |
Neurophysiology | Decay kinetics of miniature post synaptic currents | No change | Whole-cell current clamp | P17-p23 | Antoine MW , et al. (2019) |
Neurophysiology | Action potential property: rate of depolarization | No change | Whole-cell current clamp | P17-p23 | Antoine MW , et al. (2019) |
Neurophysiology | Action potential property: firing rate | No change | Whole-cell current clamp | P17-p23 | Antoine MW , et al. (2019) |
Neurophysiology | Action potential property: firing rate | Increased | Whole-cell voltage clamp | P17-p23 | Antoine MW , et al. (2019) |
Neurophysiology | Action potential property: firing rate | Increased | Cell-attached patch clamp | P17-p23 | Antoine MW , et al. (2019) |
Neurophysiology | Action potential property: amplitude | No change | Whole-cell current clamp | P17-p23 | Antoine MW , et al. (2019) |
Neurophysiology | NA | Not reported | NA | NA | Kloth AD , et al. (2015) |
Neurophysiology | NA | Not reported | NA | NA | Peagarikano O , et al. (2011) |
Repetitive behavior | NA | Not reported | NA | NA | - |
Repetitive behavior | NA | Not reported | NA | NA | Antoine MW , et al. (2019) |
Repetitive behavior | NA | Not reported | NA | NA | Kloth AD , et al. (2015) |
Repetitive behavior | Self grooming: perseveration | No change | Grooming behavior assessments | NA | Peagarikano O , et al. (2011) |
Seizure | NA | Not reported | NA | NA | - |
Seizure | NA | Not reported | NA | NA | Antoine MW , et al. (2019) |
Seizure | NA | Not reported | NA | NA | Kloth AD , et al. (2015) |
Seizure | NA | Not reported | NA | NA | Peagarikano O , et al. (2011) |
Sensory | Sensory-evoked response: excitation: tactile stimulus | Decreased | Whole-cell voltage clamp | P42-p92 | - |
Sensory | NA | Not reported | NA | NA | - |
Sensory | NA | Not reported | NA | NA | Antoine MW , et al. (2019) |
Sensory | NA | Not reported | NA | NA | Kloth AD , et al. (2015) |
Sensory | Pain or nociception | No change | Hot plate test | NA | Peagarikano O , et al. (2011) |
Social behavior | NA | Not reported | NA | NA | - |
Social behavior | NA | Not reported | NA | NA | Antoine MW , et al. (2019) |
Social behavior | NA | Not reported | NA | NA | Kloth AD , et al. (2015) |
Social behavior | Social approach | No change | Three-chamber social approach test | NA | Peagarikano O , et al. (2011) |
Physiological parameters | NA | Not reported | NA | NA | - |
Physiological parameters | NA | Not reported | NA | NA | Antoine MW , et al. (2019) |
Physiological parameters | NA | Not reported | NA | NA | Kloth AD , et al. (2015) |
Physiological parameters | NA | Not reported | NA | NA | Peagarikano O , et al. (2011) |
Communications | NA | Not reported | NA | NA | - |
Communications | NA | Not reported | NA | NA | Antoine MW , et al. (2019) |
Communications | NA | Not reported | NA | NA | Kloth AD , et al. (2015) |
Communications | Ultrasonic vocalization: isolation induced | No change | Monitoring ultrasonic vocalizations | P3,p6,p9,p12 | Peagarikano O , et al. (2011) |
Developmental profile | NA | Not reported | NA | NA | - |
Developmental profile | NA | Not reported | NA | NA | Antoine MW , et al. (2019) |
Developmental profile | NA | Not reported | NA | NA | Kloth AD , et al. (2015) |
Developmental profile | NA | Not reported | NA | NA | Peagarikano O , et al. (2011) |
Emotion | NA | Not reported | NA | NA | - |
Emotion | NA | Not reported | NA | NA | Antoine MW , et al. (2019) |
Emotion | NA | Not reported | NA | NA | Kloth AD , et al. (2015) |
Emotion | NA | Not reported | NA | NA | Peagarikano O , et al. (2011) |
Immune response | NA | Not reported | NA | NA | - |
Immune response | NA | Not reported | NA | NA | Antoine MW , et al. (2019) |
Immune response | NA | Not reported | NA | NA | Kloth AD , et al. (2015) |
Immune response | NA | Not reported | NA | NA | Peagarikano O , et al. (2011) |
Learning & memory | NA | Not reported | NA | NA | - |
Learning & memory | NA | Not reported | NA | NA | Antoine MW , et al. (2019) |
Learning & memory | Eye blink conditioning: extinction and reactivation | No change | Eyeblink conditioning | 2-4 months | Kloth AD , et al. (2015) |
Learning & memory | Eye blink conditioning | No change | Eyeblink conditioning | 2-4 months | Kloth AD , et al. (2015) |
Learning & memory | Spatial working memory | No change | T-maze test | NA | Peagarikano O , et al. (2011) |
Learning & memory | Spatial learning | No change | Morris water maze test | NA | Peagarikano O , et al. (2011) |
Learning & memory | Cognitive flexibility | No change | Morris water maze test | NA | Peagarikano O , et al. (2011) |
Maternal behavior | NA | Not reported | NA | NA | - |
Maternal behavior | NA | Not reported | NA | NA | Antoine MW , et al. (2019) |
Maternal behavior | NA | Not reported | NA | NA | Kloth AD , et al. (2015) |
Maternal behavior | NA | Not reported | NA | NA | Peagarikano O , et al. (2011) |
Molecular profile | NA | Not reported | NA | NA | - |
Molecular profile | NA | Not reported | NA | NA | Antoine MW , et al. (2019) |
Molecular profile | NA | Not reported | NA | NA | Kloth AD , et al. (2015) |
Molecular profile | NA | Not reported | NA | NA | Peagarikano O , et al. (2011) |
M_CNTNAP2_7_KO_HM_LPS
Model Type: Multifactorial
Model Genotype: Homozygous
Mutation:
Homozygous Cntnap2 KO mice are obtained by crossing heterozygous Cntnap2 KO mice and subjecting the pregnant females to a MIA at gestational day GD7 (0.30 mg/kg LPS in saline by subcutaneous injections).
Allele Type: Knockout
Strain of Origin: (129X1/SvJ x 129S1/Sv)F1-Kitl+
Genetic Background: C57BL/6J
Es cell line: R1
Model Source: Peles lab
Category | Entity | Value Change | Experimental Paradigm | Age at Testing | Author, Year |
---|---|---|---|---|---|
Circadian sleep/wake cycle | NA | Not reported | NA | NA | Schaafsma SM , et al. (2017) |
Motor phenotype | General locomotor activity | Increased | Open field test | P40 | Schaafsma SM , et al. (2017) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Neuroreceptor levels: crh | No change | Quantitative pcr (qrt-pcr) | P40 | Schaafsma SM , et al. (2017) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Neuroreceptor levels: crh | Decreased | Quantitative pcr (qrt-pcr) | P40 | Schaafsma SM , et al. (2017) |
Neurophysiology | NA | Not reported | NA | NA | Schaafsma SM , et al. (2017) |
Repetitive behavior | NA | Not reported | NA | NA | Schaafsma SM , et al. (2017) |
Seizure | NA | Not reported | NA | NA | Schaafsma SM , et al. (2017) |
Sensory | NA | Not reported | NA | NA | Schaafsma SM , et al. (2017) |
Social behavior | Social habituation | Decreased | Social recognition test | 6 weeks | Schaafsma SM , et al. (2017) |
Social behavior | Social habituation | Decreased | Social recognition test | 6 weeks | Schaafsma SM , et al. (2017) |
Social behavior | Social dishabituation | Decreased | Social recognition test | 6 weeks | Schaafsma SM , et al. (2017) |
Physiological parameters | NA | Not reported | NA | NA | Schaafsma SM , et al. (2017) |
Communications | Ultrasonic vocalization: isolation induced | Decreased | Monitoring ultrasonic vocalizations | P3 | Schaafsma SM , et al. (2017) |
Developmental profile | NA | Not reported | NA | NA | Schaafsma SM , et al. (2017) |
Emotion | Anxiety | No change | Open field test | P40 | Schaafsma SM , et al. (2017) |
Immune response | NA | Not reported | NA | NA | Schaafsma SM , et al. (2017) |
Learning & memory | NA | Not reported | NA | NA | Schaafsma SM , et al. (2017) |
Maternal behavior | NA | Not reported | NA | NA | Schaafsma SM , et al. (2017) |
Molecular profile | Gene expression | No change | Quantitative pcr (qrt-pcr) | P40 | Schaafsma SM , et al. (2017) |
Molecular profile | Chromatin modification | No change | Quantitative pcr (qrt-pcr) | P40 | Schaafsma SM , et al. (2017) |
Molecular profile | Chromatin modification | Decreased | Quantitative pcr (qrt-pcr) | P40 | Schaafsma SM , et al. (2017) |
M_CNTNAP2_9_KO_HM_MIA
Model Type: Multifactorial
Model Genotype: Homozygous
Mutation:
Homozygous Cntnap2 KO mice are obtained by crossing heterozygous Cntnap2 KO mice and subjecting the pregnant females to a MIA at gestational day GD7 (0.30 mg/kg LPS in saline by subcutaneous injections).
Allele Type: Knockout
Strain of Origin: -
Genetic Background: C57BL/6J
Es cell line: -
Model Source: -
Category | Entity | Value Change | Experimental Paradigm | Age at Testing | Author, Year |
---|---|---|---|---|---|
Circadian sleep/wake cycle | NA | Not reported | NA | NA | Schaafsma SM , et al. (2017) |
Motor phenotype | NA | Not reported | NA | NA | Schaafsma SM , et al. (2017) |
Neuroanatomy / ultrastructure / cytoarchitecture | NA | Not reported | NA | NA | Schaafsma SM , et al. (2017) |
Neurophysiology | NA | Not reported | NA | NA | Schaafsma SM , et al. (2017) |
Repetitive behavior | NA | Not reported | NA | NA | Schaafsma SM , et al. (2017) |
Seizure | NA | Not reported | NA | NA | Schaafsma SM , et al. (2017) |
Sensory | NA | Not reported | NA | NA | Schaafsma SM , et al. (2017) |
Social behavior | Social habituation | Decreased | Social recognition test | 6 weeks | Schaafsma SM , et al. (2017) |
Physiological parameters | NA | Not reported | NA | NA | Schaafsma SM , et al. (2017) |
Communications | NA | Not reported | NA | NA | Schaafsma SM , et al. (2017) |
Developmental profile | NA | Not reported | NA | NA | Schaafsma SM , et al. (2017) |
Emotion | NA | Not reported | NA | NA | Schaafsma SM , et al. (2017) |
Immune response | NA | Not reported | NA | NA | Schaafsma SM , et al. (2017) |
Learning & memory | NA | Not reported | NA | NA | Schaafsma SM , et al. (2017) |
Maternal behavior | NA | Not reported | NA | NA | Schaafsma SM , et al. (2017) |
Molecular profile | NA | Not reported | NA | NA | Schaafsma SM , et al. (2017) |
Other CNTNAP2 Rescue Models(34 Models)
M_CNTNAP2_2_KO_HM | 1 | Genetic | Genetic | Human CNTNAP2 |
M_CNTNAP2_5_KO_HM | 1 | Genetic | Pharmacological | 7-nitroindazole |
M_CNTNAP2_5_KO_HM | 3 | Genetic | Pharmaceutical | Arginine vasopressin |
M_CNTNAP2_5_KO_HM | 1 | Genetic | Pharmaceutical | Arginine vasopressin;L371,257 |
M_CNTNAP2_5_KO_HM | 1 | Genetic | Pharmaceutical | Arginine vasopressin;Relcovaptan |
M_CNTNAP2_5_KO_HM | 1 | Genetic | Genetic | C79 gene fragment |
M_CNTNAP2_5_KO_HM | 1 | Genetic | Genetic | DREADD-Oxytocin neurons |
M_CNTNAP2_5_KO_HM | 1 | Genetic | Pharmaceutical | Fenobam |
M_CNTNAP2_5_KO_HM | 1 | Genetic | Pharmaceutical | Flumazenil |
M_CNTNAP2_5_KO_HM | 1 | Genetic | Pharmaceutical | Fluoxetine |
M_CNTNAP2_5_KO_HM | 1 | Genetic | Pharmaceutical | Recombinant interleukin 17a |
M_CNTNAP2_5_KO_HM | 1 | Genetic | Pharmaceutical | Lipopolysaccharide |
M_CNTNAP2_5_KO_HM | 2 | Genetic | Pharmaceutical | Ro27-3225 |
M_CNTNAP2_5_KO_HM | 1 | Genetic | Pharmaceutical | Ro27-3225;L371,257 |
M_CNTNAP2_5_KO_HM | 1 | Genetic | Pharmaceutical | Oxytocin;L371,257 |
M_CNTNAP2_5_KO_HM | 4 | Genetic | Pharmaceutical | Oxytocin |
M_CNTNAP2_5_KO_HM | 1 | Genetic | Procedural | Parvalbumin neuron activation |
M_CNTNAP2_5_KO_HM | 1 | Genetic | Procedural | Pyramidal neuron activation |
M_CNTNAP2_5_KO_HM | 1 | Genetic | Pharmaceutical | Risperidone |
M_CNTNAP2_5_KO_HM | 1 | Genetic | Procedural | Primary somatosensory cortex dysgranular zone (S1DZ) optogenetic inactivation |
M_CNTNAP2_5_KO_HM | 2 | Genetic | Genetic | Tau deficiency |
M_CNTNAP2_10_KI_HT | 1 | Genetic | Pharmaceutical | Isoguvacine |
M_CNTNAP2_11_KD | 1 | Genetic LOF | Pharmaceutical | CX-546 |
M_CNTNAP2_5_KO_HM_GUT | 1 | Multifactorial | Pharmaceutical | Tetrahydrobiopterin |
M_CNTNAP2_5_KO_HM_GUT | 1 | Multifactorial | Pharmaceutical | Cocaine |
M_CNTNAP2_5_KO_HM_GUT | 1 | Multifactorial | Behavioral | Cohousing |
M_CNTNAP2_5_KO_HM_GUT | 1 | Multifactorial | Procedural | Heterozygous breeding |
M_CNTNAP2_5_KO_HM_GUT | 1 | Multifactorial | Dietary | Lactobacillus reuteri |
M_CNTNAP2_5_KO_HM_GUT | 1 | Multifactorial | Pharmaceutical | Oxytocin |
M_CNTNAP2_5_KO_HM_GUT | 1 | Multifactorial | Behavioral | Separation from wildtype littermate |
M_CNTNAP2_11_KO_HM | 1 | Genetic | Genetic | AAV1-Ef1a-DIO ChETA-EYFP |
M_CNTNAP2_11_KO_HM | 1 | Genetic | Pharmaceutical | Oxytocin |
M_CNTNAP2_11_KO_HM | 1 | Genetic | Pharmaceutical | OXTR agonist TGOT |
M_CNTNAP2_12_KI_HT_I1253T | 1 | Genetic | Genetic | C79 gene fragment |
CNVs associated with CNTNAP2(1 Models)
Sort By:
7q35-q36.1 | 5 | Deletion-Duplication | 8 / 6 |